P38D
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S6 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | _______________MSKSEsPKEPEQLRKLFIGGLsFEtT |
| A0MZ66 | S492 | Sugiyama | SHTN1 KIAA1598 | NsEtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGs |
| A0MZ66 | S494 | Sugiyama | SHTN1 KIAA1598 | EtELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsVs |
| A0MZ66 | S532 | Sugiyama | SHTN1 KIAA1598 | sVssVTKTALNKKTLEAEFNsPsPPtPEPGEGPRKLEGCTS |
| A0MZ66 | T496 | Sugiyama | SHTN1 KIAA1598 | ELERILRRRKVtAEADsssPtGILAtsEsKsMPVLGsVssV |
| A0MZ66 | T537 | Sugiyama | SHTN1 KIAA1598 | TKTALNKKTLEAEFNsPsPPtPEPGEGPRKLEGCTSSKVTF |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | S243 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | PHLQKVFDRYKsysPyDMLEsIRKEVKGDLENAFLNLVQRI |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00151 | S90 | Sugiyama | PDLIM1 CLIM1 CLP36 | IKGCTDNLtLtVARsEHKVWsPLVtEEGKRHPYKMNLASEP |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00170 | S159 | Sugiyama | AIP XAP2 | DALQQNPQPLIFHMEMLKVEsPGtYQQDPWAMTDEEKAKAV |
| O00232 | S335 | Sugiyama | PSMD12 | MRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLK |
| O00418 | S359 | SIGNOR|ELM|iPTMNet|PSP | EEF2K | NTKLLQSAKtILRGtEEKCGsPQVRTLsGSRPPLLRPLsEN |
| O00418 | S396 | SIGNOR|iPTMNet|PSP | EEF2K | LsENSGDENMSDVTFDsLPSsPsSATPHSQKLDHLHWPVFS |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O00499 | S298 | Sugiyama | BIN1 AMPHL | TFtVKAQPsDNAPAKGNKsPsPPDGsPAAtPEIRVNHEPEP |
| O00499 | S303 | Sugiyama | BIN1 AMPHL | AQPsDNAPAKGNKsPsPPDGsPAAtPEIRVNHEPEPAGGAt |
| O00499 | T323 | Sugiyama | BIN1 AMPHL | sPAAtPEIRVNHEPEPAGGAtPGAtLPKsPsQLRKGPPVPP |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14545 | S480 | Sugiyama | TRAFD1 FLN29 | ATYNQLSRstsGPRPGCQPssPCVPKLsNsDsQDIQGRNRD |
| O14737 | S51 | Sugiyama | PDCD5 TFAR19 | EAKHREAEMRNsILAQVLDQsARARLsNLALVKPEKTKAVE |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O15061 | S1181 | Sugiyama | SYNM DMN KIAA0353 SYN | AAsPtGASRSVRHVTLGPGQsPLsREVIFLGPAPACPEAWG |
| O15067 | S1062 | Sugiyama | PFAS KIAA0361 | SYCLPPTFPKAsVPREPGGPsPRVAILREEGSNGDREMADA |
| O15160 | S258 | Sugiyama | POLR1C POLR1E | DITLLEPVEGEAAEELSRCFsPGVIEVQEVQGKKVARVANP |
| O15264 | S27 | Sugiyama | MAPK13 PRKM13 SAPK4 | KGFYKQDVNKTAWELPKTYVsPTHVGSGAyGsVCsAIDKRS |
| O15264 | S278 | Sugiyama | MAPK13 PRKM13 SAPK4 | YIQSLPQtPRKDFTQLFPRAsPQAADLLEKMLELDVDKRLT |
| O15264 | S350 | Sugiyama | MAPK13 PRKM13 SAPK4 | HEKLTVDEWKQHIYKEIVNFsPIARKDSRRRSGMKL_____ |
| O15264 | S38 | Sugiyama | MAPK13 PRKM13 SAPK4 | AWELPKTYVsPTHVGSGAyGsVCsAIDKRSGEKVAIKKLSR |
| O15264 | S41 | Sugiyama | MAPK13 PRKM13 SAPK4 | LPKTYVsPTHVGSGAyGsVCsAIDKRSGEKVAIKKLSRPFQ |
| O15264 | T180 | Sugiyama | MAPK13 PRKM13 SAPK4 | EDCELKILDFGLARHADAEMtGyVVtRWYRAPEVILSWMHY |
| O15264 | T265 | Sugiyama | MAPK13 PRKM13 SAPK4 | EFVQKLNDKAAKSYIQSLPQtPRKDFTQLFPRAsPQAADLL |
| O15264 | Y182 | Sugiyama | MAPK13 PRKM13 SAPK4 | CELKILDFGLARHADAEMtGyVVtRWYRAPEVILSWMHYNQ |
| O15264 | Y36 | Sugiyama | MAPK13 PRKM13 SAPK4 | KTAWELPKTYVsPTHVGSGAyGsVCsAIDKRSGEKVAIKKL |
| O15371 | S308 | Sugiyama | EIF3D EIF3S7 | LLTVSETANEPPQDEGNsFNsPRNLAMEAtyINHNFsQQCL |
| O43237 | S194 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | ERKFVKDFQDyMEPEEGCQGsPQRRGPLtsGsDEENVALPL |
| O43707 | T612 | Sugiyama | ACTN4 | KEAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVPK |
| O43847 | S106 | Sugiyama | NRDC NRD1 | sEEEGRRGsLsNAGDPEIVKsPsDPKQYRYIKLQNGLQALL |
| O43847 | S108 | Sugiyama | NRDC NRD1 | EEGRRGsLsNAGDPEIVKsPsDPKQYRYIKLQNGLQALLIS |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60333 | S649 | Sugiyama | KIF1B KIAA0591 KIAA1448 | NHVFRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELLEK |
| O60333 | T652 | Sugiyama | KIF1B KIAA0591 KIAA1448 | FRFNHPEQARAEREKtPsAEtPsEPVDWTFAQRELLEKQGI |
| O60361 | S107 | Sugiyama | NME2P1 | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDY |
| O60361 | S110 | Sugiyama | NME2P1 | RGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDYKSC |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75179 | S2042 | Sugiyama | ANKRD17 GTAR KIAA0697 | TAPTNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLD |
| O75179 | S2045 | Sugiyama | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75376 | S157 | Sugiyama | NCOR1 KIAA1047 | LRASADAKKDPAFGGKHEAPssPIsGQPCGDDQNAsPsKLS |
| O75391 | S158 | Sugiyama | SPAG7 | LKELAQRQEEEAAQQGPVVVsPAsDyKDKYSHLIGKGAAKD |
| O75410 | S276 | Sugiyama | TACC1 KIAA1103 | GtPLPKAsYHFsPEELDENtsPLLGDARFQKsPPDLKETPG |
| O75533 | T223 | Sugiyama | SF3B1 SAP155 | tADQtPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsE |
| O75533 | T227 | Sugiyama | SF3B1 SAP155 | tPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsEtPGA |
| O75794 | S299 | Sugiyama | CDC123 C10orf7 D123 | AQEQDSPAFRCTNSEVtVQPsPyLsyRLPKDFVDLsTGEDA |
| O75822 | T109 | Sugiyama | EIF3J EIF3S1 PRO0391 | KKRQEEIKKRLEEPEEPKVLtPEEQLADKLRLKKLQEEsDL |
| O75828 | S56 | Sugiyama | CBR3 SDR21C2 | TARDVARGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| O94776 | S435 | Sugiyama | MTA2 MTA1L1 PID | RGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFL |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O94979 | S188 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | PEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVS |
| O95067 | S392 | Sugiyama | CCNB2 | KLLKISMIPQLNSKAVKDLAsPLIGRs______________ |
| O95359 | S2317 | Sugiyama | TACC2 | MPLRRPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTF |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O95365 | S549 | Sugiyama | ZBTB7A FBI1 LRF ZBTB7 ZNF857A | ARRNGQEKHFKDEDEDEDVAsPDGLGRLNVAGAGGGGDsGG |
| O95817 | S289 | Sugiyama | BAG3 BIS | sVQGAssREGsPARsstPLHsPsPIRVHtVVDRPQQPMTHR |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00367 | T410 | Sugiyama | GLUD1 GLUD | KSNAPRVKAKIIAEGANGPttPEADKIFLERNIMVIPDLYL |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P00966 | T174 | Sugiyama | ASS1 ASS | FKGRNDLMEyAKQHGIPIPVtPKNPWSMDENLMHIsyEAGI |
| P00966 | T219 | Sugiyama | ASS1 ASS | KNQAPPGLytKtQDPAKAPNtPDILEIEFKKGVPVKVTNVK |
| P04040 | T28 | Sugiyama | CAT | ASDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRG |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S170 | Sugiyama | ANXA1 ANX1 LPC1 | RDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsE |
| P04083 | S34 | Sugiyama | ANXA1 ANX1 LPC1 | IENEEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKA |
| P04083 | S37 | Sugiyama | ANXA1 ANX1 LPC1 | EEQEyVQtVKssKGGPGsAVsPyPtFNPssDVAALHKAIMV |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T103 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sKIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRVIIsA |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04637 | S33 | SIGNOR | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S46 | SIGNOR | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04843 | S385 | Sugiyama | RPN1 | IDSLTVKIILPEGAKNIEIDsPyEISRAPDELHYTYLDTFG |
| P05023 | S722 | Sugiyama | ATP1A1 | VEGCQRQGAIVAVTGDGVNDsPALKKADIGVAMGIAGSDVS |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S17 | Sugiyama | RPLP2 D11S2243E RPP2 | ____MRyVAsyLLAALGGNssPsAKDIKKILDsVGIEADDD |
| P05387 | S79 | Sugiyama | RPLP2 D11S2243E RPP2 | IGKLAsVPAGGAVAVsAAPGsAAPAAGsAPAAAEEKKDEKK |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S74 | SIGNOR | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S263 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsF |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | S243 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | PHLQKVFDRYKsysPyDMLEsIRKEVKGDLENAFLNLVQCI |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S168 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| P07437 | S172 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | ISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSVHQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T166 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GMGTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07686 | T307 | Sugiyama | HEXB HCC7 | PEFDTPGHTLSWGKGQKDLLtPCySRQNKLDSFGPINPTLN |
| P07737 | S28 | Sugiyama | PFN1 | IDNLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEV |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S688 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | DIIQLQRRGFFICDQPyEPVsPysCKEAPCVLIyIPDGHtK |
| P07814 | S691 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | QLQRRGFFICDQPyEPVsPysCKEAPCVLIyIPDGHtKEMP |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S543 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKKQEE |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07942 | S658 | Sugiyama | LAMB1 | PTSSRCGNTIPDDDNQVVsLsPGSRYVVLPRPVCFEKGTNY |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T537 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEESK |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08651 | S323 | Sugiyama | NFIC NFI | PssPtsSSRNWTEDMEGGIssPVKKtEMDKsPFNsPsPQDs |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09234 | S17 | Sugiyama | SNRPC | ____MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENVKDY |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S6 | Sugiyama | HNRNPA1 HNRPA1 | _______________MsKsEsPKEPEQLRKLFIGGLsFEtT |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | T455 | Sugiyama | HSPD1 HSP60 | GIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLKIP |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11388 | S1247 | Sugiyama | TOP2A TOP2 | MKAEAEKKNKKKIKNENtEGsPQEDGVELEGLKQRLEKKQK |
| P11388 | T1244 | Sugiyama | TOP2A TOP2 | TIEMKAEAEKKNKKKIKNENtEGsPQEDGVELEGLKQRLEK |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11586 | T148 | Sugiyama | MTHFD1 MTHFC MTHFD | tsINAGKLARGDLNDCFIPCtPKGCLELIKETGVPIAGRHA |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | T35 | Sugiyama | CKB CKBB | PAEDEFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDD |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12429 | Y15 | Sugiyama | ANXA3 ANX3 | ______MASIWVGHRGTVRDyPDFsPsVDAEAIQKAIRGIG |
| P13051 | S64 | Sugiyama | UNG DGU UNG1 UNG15 | AAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAAALLR |
| P13637 | S712 | Sugiyama | ATP1A3 | VEGCQRQGAIVAVTGDGVNDsPALKKADIGVAMGIAGSDVS |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S595 | Sugiyama | EEF2 EF2 | PVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGLAE |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13798 | S304 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | YVDLIGGKCELLSDDsLAVssPRLSPDQCRIVYLQYPSLIP |
| P13804 | S192 | Sugiyama | ETFA | sFDAAATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPEL |
| P13807 | S645 | Sugiyama | GYS1 GYS | PNEADAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRN |
| P13807 | S649 | Sugiyama | GYS1 GYS | DAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRNGPLE |
| P13807 | S723 | PSP | GYS1 GYS | TSGSKRNsVDtAtsssLstPsEPLsPtssLGEERN______ |
| P13807 | S727 | PSP | GYS1 GYS | KRNsVDtAtsssLstPsEPLsPtssLGEERN__________ |
| P13807 | T278 | PSP | GYS1 GYS | VSQITAIEAQHLLKRKPDIVtPNGLNVKKFsAMHEFQNLHA |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | S442 | Sugiyama | PRKCSH G19P1 | EYVYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSA |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14550 | S211 | Sugiyama | AKR1A1 ALDR1 ALR | LAQNELIAHCQARGLEVTAysPLGSSDRAWRDPDEPVLLEE |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | T41 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtL |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14854 | S52 | Sugiyama | COX6B1 COX6B | QNyLDFHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTD |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P14868 | T370 | Sugiyama | DARS1 DARS PIG40 | EALAMLREAGVEMGDEDDLstPNEKLLGHLVKEKyDTDFyI |
| P15336 | T69 | Sugiyama | ATF2 CREB2 CREBP1 | HEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELA |
| P15336 | T71 | Sugiyama | ATF2 CREB2 CREBP1 | MtLKFGPARNDsVIVADQtPtPtRFLKNCEEVGLFNELAsP |
| P15531 | S125 | Sugiyama | NME1 NDPKA NM23 | RGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDyTsC |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P16152 | S56 | Sugiyama | CBR1 CBR CRN SDR21C1 | TARDVTRGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| P16278 | S434 | Sugiyama | GLB1 ELNR1 | GFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQGV |
| P16949 | S25 | SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | STMN1 C1orf215 LAP18 OP18 | DIQVKELEKRAsGQAFELILsPRsKEsVPEFPLsPPKKKDL |
| P16949 | S38 | SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17174 | S93 | Sugiyama | GOT1 | PILGLAEFRsCAsRLALGDDsPALKEKRVGGVQsLGGtGAL |
| P17544 | T51 | Sugiyama | ATF7 ATFA | HEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELA |
| P17544 | T53 | Sugiyama | ATF7 ATFA | MTLKFGPARtDsVIIADQtPtPtRFLKNCEEVGLFNELASS |
| P17812 | S210 | Sugiyama | CTPS1 CTPS | GEQKTKPTQNSVRELRGLGLsPDLVVCRCSNPLDTSVKEKI |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17980 | S376 | Sugiyama | PSMC3 TBP1 | MPNEEARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQC |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18827 | S233 | Sugiyama | SDC1 SDC | FETSGENTAVVAVEPDRRNQsPVDQGAtGAsQGLLDRKEVL |
| P18850 | S104 | Sugiyama | ATF6 | KDIKAEPQPLsPAssSYsVssPRSVDSYSSTQHVPEELDLS |
| P18850 | S94 | Sugiyama | ATF6 | WDINNQICTVKDIKAEPQPLsPAssSYsVssPRSVDSYSST |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21333 | S1459 | Sugiyama | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P21333 | S1630 | Sugiyama | FLNA FLN FLN1 | PDVTGRYTILIKYGGDEIPFsPyRVRAVPTGDASKCTVTVS |
| P21333 | S2319 | Sugiyama | FLNA FLN FLN1 | VQEPGDyEVsVKFNEEHIPDsPFVVPVAsPsGDARRLtVss |
| P21333 | S2327 | Sugiyama | FLNA FLN FLN1 | VsVKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKV |
| P21333 | S2329 | Sugiyama | FLNA FLN FLN1 | VKFNEEHIPDsPFVVPVAsPsGDARRLtVssLQEsGLKVNQ |
| P21333 | S2370 | Sugiyama | FLNA FLN FLN1 | PASFAVSLNGAKGAIDAKVHsPsGALEECyVtEIDQDKYAV |
| P21333 | S481 | Sugiyama | FLNA FLN FLN1 | AGVPIPRsPyTVtVGQACNPsACRAVGRGLQPKGVRVKETA |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P22392 | S122 | Sugiyama | NME2 NM23B | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDy |
| P22392 | S125 | Sugiyama | NME2 NM23B | RGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDyKSC |
| P22681 | T568 | Sugiyama | CBL CBL2 RNF55 | PDRPysVGAEsRPQRRPLPCtPGDCPSRDKLPPVPSSRLGD |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23528 | S156 | Sugiyama | CFL1 CFL | QANCyEEVKDRCTLAEKLGGsAVIsLEGKPL__________ |
| P23528 | S160 | Sugiyama | CFL1 CFL | yEEVKDRCTLAEKLGGsAVIsLEGKPL______________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23921 | S559 | Sugiyama | RRM1 RR1 | ALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPTDLW |
| P24534 | S8 | Sugiyama | EEF1B2 EEF1B EF1B | _____________MGFGDLKsPAGLQVLNDyLADKSYIEGY |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T465 | Sugiyama | MSN | WQQKAQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDE |
| P26038 | T469 | Sugiyama | MSN | AQMVQEDLEKTRAELKtAMstPHVAEPAENEQDEQDENGAE |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26640 | S301 | Sugiyama | VARS1 G7A VARS VARS2 | DLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFFKP |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | T521 | Sugiyama | MAP4 | GLLKDMsPLsEtEMALGKDVtPPPEtEVVLIKNVCLPPEME |
| P27816 | T571 | Sugiyama | MAP4 | ALKTEAPLAKDGVLtLANNVtPAKDVPPLsEtEAtPVPIKD |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28715 | S384 | Sugiyama | ERCC5 ERCM2 XPG XPGC | ENRRQARGRNAPAAVDEGsIsPRtLSAIKRALDDDEDVKVC |
| P28799 | T180 | Sugiyama | GRN | DRVHCCPHGAFCDLVHTRCItPtGTHPLAKKLPAQRTNRAV |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29966 | S101 | Sugiyama | MARCKS MACS PRKCSL | sPsAAEKGEPAAAAAPEAGAsPVEKEAPAEGEAAEPGsPtA |
| P29966 | S26 | Sugiyama | MARCKS MACS PRKCSL | SKTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAs |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P30041 | T221 | Sugiyama | PRDX6 AOP2 KIAA0106 | LFPKGVFtKELPSGKKYLRYtPQP_________________ |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30041 | T49 | Sugiyama | PRDX6 AOP2 KIAA0106 | LGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKLI |
| P30043 | S82 | Sugiyama | BLVRB FLR SCAN | DKTVAGQDAVIVLLGTRNDLsPTTVMSEGARNIVAAMKAHG |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | T42 | Sugiyama | PEBP1 PBP PEBP | QHPLHVTYAGAAVDELGKVLtPtQVKNRPtsIsWDGLDsGK |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30281 | T283 | PSP | CCND3 | ssPAPKAPRGsssQGPsQtstPtDVtAIHL___________ |
| P31150 | S316 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | QVIRIICILSHPIKNtNDANsCQIIIPQNQVNRKSDIYVCM |
| P31150 | T311 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | VRKAGQVIRIICILSHPIKNtNDANsCQIIIPQNQVNRKSD |
| P31749 | T308 | Sugiyama | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P31751 | T309 | Sugiyama | AKT2 | IKITDFGLCKEGISDGATMKtFCGtPEyLAPEVLEDNDyGR |
| P31937 | S88 | Sugiyama | HIBADH | YDVFPDACKEFQDAGEQVVSsPADVAEKADRIITMLPTSIN |
| P31939 | S269 | Sugiyama | ATIC PURH OK/SW-cl.86 | LVKELKEALGIPAAAsFKHVsPAGAAVGIPLsEDEAKVCMV |
| P31939 | S300 | Sugiyama | ATIC PURH OK/SW-cl.86 | sEDEAKVCMVyDLyKTLtPIsAAyARARGADRMssFGDFVA |
| P31939 | T297 | Sugiyama | ATIC PURH OK/SW-cl.86 | IPLsEDEAKVCMVyDLyKTLtPIsAAyARARGADRMssFGD |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S248 | Sugiyama | SFN HME1 | tLWTADNAGEEGGEAPQEPQs____________________ |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32322 | S294 | Sugiyama | PYCR1 | QEQVSPAAIKKTILDKVKLDsPAGtALsPsGHTKLLPRSLA |
| P32322 | S301 | Sugiyama | PYCR1 | AIKKTILDKVKLDsPAGtALsPsGHTKLLPRSLAPAGKD__ |
| P32322 | S303 | Sugiyama | PYCR1 | KKTILDKVKLDsPAGtALsPsGHTKLLPRSLAPAGKD____ |
| P33176 | S175 | Sugiyama | KIF5B KNS KNS1 | VHEDKNRVPYVKGCTERFVCsPDEVMDtIDEGKSNRHVAVT |
| P33240 | S336 | Sugiyama | CSTF2 | PtPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPM |
| P33991 | T854 | Sugiyama | MCM4 CDC21 | AITKDMFEEALRALADDDFLtVtGKtVRLL___________ |
| P33991 | T859 | Sugiyama | MCM4 CDC21 | MFEEALRALADDDFLtVtGKtVRLL________________ |
| P33992 | S315 | Sugiyama | MCM5 CDC46 | RVLGIQVDTDGSGRSFAGAVsPQEEEEFRRLAALPNVYEVI |
| P34897 | T420 | Sugiyama | SHMT2 | LELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFREDD |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35606 | T828 | Sugiyama | COPB2 | EEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQPSRst |
| P35611 | S355 | Sugiyama | ADD1 ADDA | AGGPDNLVLLNPEKYKAKsRsPGsPVGEGtGsPPKWQIGEQ |
| P35611 | S358 | Sugiyama | ADD1 ADDA | PDNLVLLNPEKYKAKsRsPGsPVGEGtGsPPKWQIGEQEFE |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41252 | S1047 | Sugiyama | IARS1 IARS | ESHTEFIFTTIKAPLKPYPVsPsDKVLIQEKTQLKGSELEI |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42224 | S710 | Sugiyama | STAT1 | PMELDGPKGtGyIKtELIsVsEVHPSRLQttDNLLPMsPEE |
| P42892 | S733 | Sugiyama | ECE1 | VWCSVRTPESSHEGLITDPHsPsRFRVIGSLSNSKEFSEHF |
| P43121 | T107 | Sugiyama | MCAM MUC18 | EYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKRPRSQEYR |
| P46013 | S1131 | Sugiyama | MKI67 | tPGPsEEsMtDEKTTKIACKsPPPEsVDtPtstKQWPKRSL |
| P46013 | S2105 | Sugiyama | MKI67 | tPDHTEESttDDKTTKIACKsPPPEsMDtPTstRRRPKtPL |
| P46013 | S308 | Sugiyama | MKI67 | VSRKSRPKsGGsGHAVAEPAsPEQELDQNKGKGRDVEsVQt |
| P46013 | T1139 | Sugiyama | MKI67 | MtDEKTTKIACKsPPPEsVDtPtstKQWPKRSLRKADVEEE |
| P46013 | T1261 | Sugiyama | MKI67 | VAAGKTTKIPCDsPQsDPVDtPtsTKQRPKRSIRKADVEGE |
| P46013 | T2113 | Sugiyama | MKI67 | ttDDKTTKIACKsPPPEsMDtPTstRRRPKtPLGKRDIVEE |
| P46087 | T776 | Sugiyama | NOP2 NOL1 NSUN1 | EKQQLPEQPFEKAAFQKQNDtPKGPQPPtVsPIRsSRPPPA |
| P46087 | T784 | Sugiyama | NOP2 NOL1 NSUN1 | PFEKAAFQKQNDtPKGPQPPtVsPIRsSRPPPAKRKKsQsR |
| P46108 | S41 | Sugiyama | CRK | QEAVALLQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYI |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S289 | Sugiyama | YAP1 YAP65 | MNQRIsQsAPVKQPPPLAPQsPQGGVMGGsNsNQQQQMRLQ |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P49006 | S119 | Sugiyama | MARCKSL1 MLP MRP | KLsGLsFKRNRKEGGGDssAssPtEEEQEQGEIGACsDEGT |
| P49321 | T390 | Sugiyama | NASP | EAPVLPKDGAVNGPsVVGDQtPIEPQtsIERLtEtKDGsGL |
| P49327 | T1120 | Sugiyama | FASN FAS | ESAPRRQQEQQVPILEKFCFtPHTEEGCLsERAALQEELQL |
| P49448 | T410 | Sugiyama | GLUD2 GLUDP1 | KSNAPRVKAKIIAEGANGPttPEADKIFLERNILVIPDLYL |
| P49585 | S347 | Sugiyama | PCYT1A CTPCT PCYT1 | ERsPsPSFRWPFsGKtsPPCsPANLsRHKAAAyDIsEDEED |
| P49753 | S360 | Sugiyama | ACOT2 PTE2 PTE2A | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| P49792 | T1144 | Sugiyama | RANBP2 NUP358 | GFRRsDDMFTFHGPGKsVFGtPtLETANKNHEtDGGsAHGD |
| P49792 | T1761 | Sugiyama | RANBP2 NUP358 | ATKCIACQCPSKQNQtTAIstPAssEIsKAPKsGFEGMFIR |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49903 | T387 | Sugiyama | SEPHS1 SELD SPS SPS1 | IDKPRIIEVAPQVATQNVNPtPGAts_______________ |
| P50395 | S316 | Sugiyama | GDI2 RABGDIB | QVIRVICILSHPIKNtNDANsCQIIIPQNQVNRKSDIyVCM |
| P50395 | T311 | Sugiyama | GDI2 RABGDIB | VEKVGQVIRVICILSHPIKNtNDANsCQIIIPQNQVNRKSD |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P50552 | T335 | Sugiyama | VASP | tTLPRMKssssVttsEtQPCtPsSSDySDLQRVKQELLEEV |
| P50895 | S296 | Sugiyama | BCAM LU MSK19 | TPAGWVREGDTVQLLCRGDGsPsPEYTLFRLQDEQEEVLNV |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P50993 | S719 | Sugiyama | ATP1A2 KIAA0778 | VEGCQRQGAIVAVTGDGVNDsPALKKADIGIAMGISGSDVS |
| P52564 | S26 | Sugiyama | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 | GKKRNPGLKIPKEAFEQPQtsstPPRDLDsKACISIGNQNF |
| P52564 | S35 | Sugiyama | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 | IPKEAFEQPQtsstPPRDLDsKACISIGNQNFEVKADDLEP |
| P52564 | T25 | Sugiyama | MAP2K6 MEK6 MKK6 PRKMK6 SKK3 | KGKKRNPGLKIPKEAFEQPQtsstPPRDLDsKACISIGNQN |
| P52565 | T160 | Sugiyama | ARHGDIA GDIA1 | DKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYsIKSR |
| P52701 | S292 | Sugiyama | MSH6 GTBP | EGssDEIssGVGDsESEGLNsPVKVARKRKRMVTGNGsLKR |
| P52948 | S1028 | Sugiyama | NUP98 ADAR2 | ALDQRFSRLPsKADtsQEICsPRLPIsAsHssKtRsLVGGL |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53621 | S173 | Sugiyama | COPA | ASLDQTVRVWDISGLRKKNLsPGAVEsDVRGITGVDLFGTT |
| P53634 | T458 | Sugiyama | CTSC CPPI | yFRIRRGtDECAIEsIAVAAtPIPKL_______________ |
| P53992 | S328 | Sugiyama | SEC24C KIAA0079 | sQPGPPQPLPPKRLDPDAIPsPIQVIEDDRNNRGTEPFVTG |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54105 | T223 | Sugiyama | CLNS1A CLCI ICLN | AGVRtEDsIRDyEDGMEVDttPtVAGQFEDADVDH______ |
| P54646 | Y179 | Sugiyama | PRKAA2 AMPK AMPK2 | GLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVDIWS |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54727 | T155 | Sugiyama | RAD23B | SEPAPASAAKQEKPAEKPAEtPVAtsPtAtDstsGDssRSN |
| P55036 | S115 | Sugiyama | PSMD4 MCB1 | LALKHRQGKNHKMRIIAFVGsPVEDNEKDLVKLAKRLKKEK |
| P55060 | T341 | Sugiyama | CSE1L CAS XPO2 | LASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEA |
| P55209 | T62 | Sugiyama | NAP1L1 NRP | MMQNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALK |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55211 | S302 | Sugiyama | CASP9 MCH6 | FFIQACGGEQKDHGFEVAstsPEDEsPGsNPEPDATPFQEG |
| P55789 | S59 | Sugiyama | GFER ALR HERV1 HPO | AGRRDAAASASTPAQAPTsDsPVAEDASRRRPCRACVDFKT |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P57740 | S11 | Sugiyama | NUP107 | __________MDRsGFGEIssPVIREAEVTRTARKQSAQKR |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | S80 | Sugiyama | TPI1 TPI | IAVAAQNCyKVTNGAFtGEIsPGMIKDCGAtWVVLGHsERR |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60228 | S203 | Sugiyama | EIF3E EIF3S6 INT6 | DAAMEDLTRLKETIDNNSVSsPLQSLQQRTWLIHWSLFVFF |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60866 | T9 | Sugiyama | RPS20 | ____________MAFKDtGKtPVEPEVAIHRIRITLTSRNV |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | S32 | Sugiyama | RPL26 | sKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRKD |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61371 | S269 | PSP | ISL1 | QQPNDKTNIQGMtGtPMVAAsPERHDGGLQANPVEVQSYQP |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S81 | Sugiyama | HNRNPK HNRPK | GGKNIKALRtDyNAsVsVPDssGPERILsISADIETIGEIL |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62263 | Y72 | Sugiyama | RPS14 PRO2640 | TICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGITA |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62304 | S89 | Sugiyama | SNRPE | KSRKQLGRIMLKGDNITLLQsVsN_________________ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63241 | S75 | Sugiyama | EIF5A | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| P63241 | T76 | Sugiyama | EIF5A | VHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQD |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78347 | S210 | Sugiyama | GTF2I BAP135 WBSCR6 | EPKKHVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGI |
| P80723 | T36 | Sugiyama | BASP1 NAP22 | DEKAKEKDKKAEGAAtEEEGtPKEsEPQAAAEPAEAKEGKE |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| P85037 | T436 | Sugiyama | FOXK1 MNF | sAPAsPtHPGLMsPRsGGLQtPECLsREGsPIPHDPEFGsK |
| P98082 | T329 | Sugiyama | DAB2 DOC2 | SSFDsLKsPDQKKENssssstPLsNGPLNGDVDyFGQQFDQ |
| Q00613 | S303 | PSP | HSF1 HSTF1 | SIDERPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDt |
| Q00613 | S307 | PSP | HSF1 HSTF1 | RPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDtLLsP |
| Q00613 | S326 | PSP | HSF1 HSTF1 | QsPRVEEAsPGRPssVDtLLsPtALIDsILREsEPAPAsVT |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00613 | T367 | Sugiyama | HSF1 HSTF1 | ALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNELSDH |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q02952 | S286 | Sugiyama | AKAP12 AKAP250 | KEEGEEKQEKEPSKsAEsPtsPVtsETGstFKKFFTQGWAG |
| Q02952 | S483 | Sugiyama | AKAP12 AKAP250 | LVKLKEtCVsGEDPTQGADLsPDEKVLSKPPEGVVSEVEML |
| Q04637 | S1231 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | tEDRDRGRDAVKREAALPPVsPLKAALsEEELEKKsKAIIE |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07866 | S460 | Sugiyama | KLC1 KLC KNS2 | QKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGALyRRQGKF |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08AD1 | S673 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | DASKFLQDyDIRTGNTREALsPCPsTVsTKSQPGSSAssss |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q08J23 | S751 | Sugiyama | NSUN2 SAKI TRM4 | DVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGVHPPR____ |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09666 | S177 | Sugiyama | AHNAK PM227 | VtAytVDVTGREGAKDIDIssPEFKIKIPRHELtEISNVDV |
| Q09666 | S41 | Sugiyama | AHNAK PM227 | HGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGATIy |
| Q09666 | S93 | Sugiyama | AHNAK PM227 | LLNTMGHHTVGLKLHRKGDRsPEPGQtWtREVFssCssEVV |
| Q09666 | T3716 | Sugiyama | AHNAK PM227 | VEGDLKGPEVDIKGPKVDIDtPDINIEGsEGKFKGPKFKIP |
| Q09666 | T4100 | Sugiyama | AHNAK PM227 | VDVNLPKADIDVsGPKVDIDtPDIDIHGPEGKLKGPKFKMP |
| Q09666 | T4564 | Sugiyama | AHNAK PM227 | LEGDLKGPKVDVKGPKVGIDtPDIDIHGPEGKLKGPKFKMP |
| Q12774 | S445 | Sugiyama | ARHGEF5 TIM | ASYLMTQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISL |
| Q12774 | S450 | Sugiyama | ARHGEF5 TIM | TQIPGTQTESRAEELsPAALsPsLEPIRCSHQPISLLGsFL |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q12888 | T1609 | SIGNOR | TP53BP1 | SLEQGNRLREQYGLGPYEAVtPLtKAADIsLDNLVEGKRKR |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q13017 | S968 | Sugiyama | ARHGAP5 RHOGAP5 | SYLsDNtRESTHQSEDVFLPsPRDCFPyNNyPDsDDDtEAP |
| Q13131 | Y190 | Sugiyama | PRKAA1 AMPK1 | GLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVDIWS |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13242 | S216 | Sugiyama | SRSF9 SFRS9 SRP30C | RSGsRGRDsPyQsRGsPHyFsPFRPy_______________ |
| Q13263 | S757 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKLTE |
| Q13263 | Y755 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | GGTLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKL |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13409 | T95 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | IVFSEYWVPPPMsPSSKsVStPsEAGsQDsGDGAVGsRTLH |
| Q13428 | T1014 | Sugiyama | TCOF1 | ARssssEsEDEDVIPAtQCLtPGIRTNVVTMPTAHPRIAPK |
| Q13428 | T102 | Sugiyama | TCOF1 | IstsEssEEEEEAEAETAKAtPRLAstNssVLGADLPssMK |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13451 | S13 | Sugiyama | FKBP5 AIG6 FKBP51 | ________MttDEGAKNNEEsPtAtVAEQGEDITsKKDRGV |
| Q13501 | S272 | PSP | SQSTM1 ORCA OSIL | GIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssCCsD |
| Q13501 | T269 | PSP | SQSTM1 ORCA OSIL | sPLGIEVDIDVEHGGKRsRLtPVsPEssstEEKsssQPssC |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S168 | Sugiyama | TUBB3 TUBB4 | GTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| Q13509 | S172 | Sugiyama | TUBB3 TUBB4 | ISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSIHQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | T166 | Sugiyama | TUBB3 TUBB4 | GMGTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13541 | S65 | Sugiyama | EIF4EBP1 | ttPGGtRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPs |
| Q13561 | S202 | Sugiyama | DCTN2 DCTN50 | EATKNSKGGSGGKttGtPPDssLVtyELHsRPEQDKFSQAA |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13573 | S232 | Sugiyama | SNW1 SKIIP SKIP | FKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCIS |
| Q13586 | S621 | Sugiyama | STIM1 GOK | PsAPPGGsPHLDssRsHsPssPDPDtPsPVGDSRALQASRN |
| Q13586 | T626 | Sugiyama | STIM1 GOK | GGsPHLDssRsHsPssPDPDtPsPVGDSRALQASRNTRIPH |
| Q13610 | S57 | Sugiyama | PWP1 | AEAKEKLQEEGGGsDEEEtGsPsEDGMQsARTQARPREPLE |
| Q13620 | S146 | Sugiyama | CUL4B KIAA0695 | EFVGFDAKMAEEsssssssssPtAATSQQQQLKNKsILISS |
| Q13884 | S87 | Sugiyama | SNTB1 SNT2B1 | SFCRGAGAGHPGAGGAQPPDsPAGVRTAFTDLPEQVPESIS |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14157 | S416 | Sugiyama | UBAP2L KIAA0144 NICE4 | tQsPsLVQYDLKNPsDsAVHsPFtKRQAFtPsstMMEVFLQ |
| Q14157 | S470 | Sugiyama | UBAP2L KIAA0144 NICE4 | PPPssPLPsKstsAPQMsPGssDNQsssPQPAQQKLKQQKK |
| Q14160 | S1448 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | QEDEQPPWAsPsPtsRQsPAsPPPLGGGAPVRTAKAERRHQ |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14204 | S2410 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GEDEAQRRRKGKEDEGEEAAsPMLQIQRDAATIMQPYFTSN |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14258 | S100 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | DLAREPPADVWtPPARAsAPsPNAQVACDHCLKEAAVKTCL |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14684 | T708 | Sugiyama | RRP1B KIAA0179 | LNRNMtAEFKKTDKsILVsPtGPsRVAFDPEQKPLHGVLKt |
| Q14697 | S58 | Sugiyama | GANAB G2AN KIAA0088 | FKtCEEssFCKRQRsIRPGLsPyRALLDSLQLGPDSLTVHL |
| Q14974 | S12 | Sugiyama | KPNB1 NTF97 | _________MELITILEKtVsPDRLELEAAQKFLERAAVEN |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15003 | S81 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | EKERLQRRRsRVFDLQFstDsPRLLAsPsSRsIDIsATIPK |
| Q15003 | T49 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | PsERVFPMPLPRKAPLNIPGtPVLEDFPQNDDEKERLQRRR |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | S248 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | LAsRYGIRGFPtIKIFQKGEsPVDyDGGRTRsDIVsRALDL |
| Q15154 | S861 | Sugiyama | PCM1 | KQLEALMAEHQRRQGLAETAsPVAVSLRSDGSENLCTPQQS |
| Q15181 | S250 | Sugiyama | PPA1 IOPPP PP | LVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDALPPPC |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15365 | S189 | Sugiyama | PCBP1 | tLsQsPQGRVMtIPyQPMPAssPVICAGGQDRCsDAAGYPH |
| Q15545 | S201 | Sugiyama | TAF7 TAF2F TAFII55 | WEIIAEDETKEAENQGLDIssPGMsGHRQGHDsLEHDELRE |
| Q15637 | S80 | Sugiyama | SF1 ZFM1 ZNF162 | DLTRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFR |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q15648 | S1479 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | QNLDsEsEsGSSIAEKsyQNsPssDDGIRPLPEYstEKHKK |
| Q15648 | S1482 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | DsEsEsGSSIAEKsyQNsPssDDGIRPLPEYstEKHKKHKK |
| Q15942 | S259 | Sugiyama | ZYX | QSQTQPVsLANtQPRGPPAssPAPAPKFsPVtPKFtPVAsK |
| Q15942 | S267 | Sugiyama | ZYX | LANtQPRGPPAssPAPAPKFsPVtPKFtPVAsKFsPGAPGG |
| Q15942 | T270 | Sugiyama | ZYX | tQPRGPPAssPAPAPKFsPVtPKFtPVAsKFsPGAPGGsGs |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16595 | S158 | Sugiyama | FXN FRDA X25 | GDLGTYVINKQTPNKQIWLSsPSSGPKRYDWTGKNWVYSHD |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16643 | T346 | Sugiyama | DBN1 D0S117E | RRMAPtPIPtRsPsDsstAstPVAEQIERALDEVTsSQPPP |
| Q16666 | S153 | Sugiyama | IFI16 IFNGIP1 | TKEKAGPKGsKVsEEQtQPPsPAGAGMstAMGRsPsPKTSL |
| Q2NL82 | T490 | Sugiyama | TSR1 KIAA1401 | KMLEKYKQERLEEMFPDEVDtPRDVAARIRFQKYRGLKSFR |
| Q32MZ4 | S16 | Sugiyama | LRRFIP1 GCF2 TRIP | _____MtsPAAAQSREIDCLsPEAQKLAEARLAAKRAARAE |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q53EZ4 | S425 | Sugiyama | CEP55 C10orf3 URCC6 | ITEPLVTFQGETENREKVAAsPKsPtAALNEsLVECPKCNI |
| Q53EZ4 | S428 | Sugiyama | CEP55 C10orf3 URCC6 | PLVTFQGETENREKVAAsPKsPtAALNEsLVECPKCNIQYP |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF7 | T410 | Sugiyama | HSP90AB3P HSP90BC | IDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEESK |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q58FF8 | T310 | Sugiyama | HSP90AB2P HSP90BB | TEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEERK |
| Q5JSH3 | S371 | Sugiyama | WDR44 RPH11 | EEILASVMIKNLDtGEEIPLsLAEEKLPTGINPLTLHIMRR |
| Q5JSH3 | S50 | Sugiyama | WDR44 RPH11 | KVGLSTFKETENTAYKVGNEsPVQELKQDVSKKIIEsIIEE |
| Q5JSH3 | S96 | Sugiyama | WDR44 RPH11 | QLEDDsLDSKGKELsDQAtAsPIVARTDLSNIPGLLAIDQV |
| Q5R3I4 | S362 | Sugiyama | TTC38 | GAHDPQTTQELLTTLRDASEsPGENCQHLLARDVGLPLCQA |
| Q5SW79 | S1529 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | PSAMLPsPPKQKssPVNNHHsPGQtPtLGQPEARALHPAAV |
| Q5SW79 | T1533 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | LPsPPKQKssPVNNHHsPGQtPtLGQPEARALHPAAVSAAA |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5THJ4 | S1042 | Sugiyama | VPS13D KIAA0453 | SHKNLsFDIPtGsLRDsRAQsPVsGPNVAHLTDGATLNDRS |
| Q5UIP0 | S2161 | Sugiyama | RIF1 | NNAsPQKLRELDPsLVsANDsPsGMQtRCVWsPLAsPStsI |
| Q5UIP0 | S2163 | Sugiyama | RIF1 | AsPQKLRELDPsLVsANDsPsGMQtRCVWsPLAsPStsILK |
| Q5VT52 | S965 | Sugiyama | RPRD2 KIAA0460 HSPC099 | NsLsQsttGHLSLPQKQyPDsPHPVPHRsLFsPQNtLAAPT |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q69YN4 | S1579 | Sugiyama | VIRMA KIAA1429 MSTP054 | CCSDFDLHSELERsFLsEPssPGRtKTTKGFKLGKHKHETF |
| Q6IS14 | S75 | Sugiyama | EIF5AL1 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| Q6IS14 | T76 | Sugiyama | EIF5AL1 | VHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQD |
| Q6JBY9 | S68 | SIGNOR | RCSD1 CAPZIP | PCSLPLFPPKVDLGQNGEEKsPPNAsHPPKFKVKssPLIEK |
| Q6P1L8 | S49 | Sugiyama | MRPL14 MRPL32 RPML32 | LSAIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKV |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PGQ7 | S558 | Sugiyama | BORA C13orf34 | KQDHTTQRCWMKTASPFQCSsP___________________ |
| Q6PKG0 | S521 | Sugiyama | LARP1 KIAA0731 LARP | NCPEFVPRQHYQKEtEsAPGsPRAVtPVPtKTEEVSNLKTL |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6PKG0 | T526 | Sugiyama | LARP1 KIAA0731 LARP | VPRQHYQKEtEsAPGsPRAVtPVPtKTEEVSNLKTLPKGLs |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ULP2 | S151 | Sugiyama | AFTPH AFTH | PGNLNKVVEQRQNVGTLESFsPGDFRTNMNVVHQNKQLESC |
| Q6VN20 | S365 | Sugiyama | RANBP10 KIAA1464 | DSEVRSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGAD |
| Q6VN20 | S367 | Sugiyama | RANBP10 KIAA1464 | EVRSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGADsP |
| Q6VN20 | S369 | Sugiyama | RANBP10 KIAA1464 | RSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGADsPsC |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7LBC6 | S778 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | DNPLLKTFsNVFGRHsGGFLssPADFsQENKAPFEAVKRFs |
| Q7LBC6 | S779 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | NPLLKTFsNVFGRHsGGFLssPADFsQENKAPFEAVKRFsL |
| Q7Z2K8 | S100 | Sugiyama | GPRIN1 KIAA1893 | GAsCSDGPRGsLACPsPtCFsPQEsPsKETLEAHGAsIsGt |
| Q7Z2K8 | T97 | Sugiyama | GPRIN1 KIAA1893 | AGEGAsCSDGPRGsLACPsPtCFsPQEsPsKETLEAHGAsI |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q7Z5K2 | S221 | Sugiyama | WAPL FOE KIAA0261 WAPAL | AsEIKETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDN |
| Q7Z5K2 | S226 | Sugiyama | WAPL FOE KIAA0261 WAPAL | ETNDTWNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDFEDI |
| Q7Z6Z7 | T2889 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | EAVGDTSAAGSSEQPRAGsstPGDAPPAVAEVQGRSDGsGE |
| Q86TX2 | S298 | Sugiyama | ACOT1 CTE1 | NRNRIKVTKDGyADIVDVLNsPLEGPDQKSFIPVERAESTF |
| Q86UE4 | S146 | Sugiyama | MTDH AEG1 LYRIC | PKPNGRTVEVAEGEAVRtPQsVtAKQPPEIDKKNEKSKKNK |
| Q86UE4 | T143 | Sugiyama | MTDH AEG1 LYRIC | SEKPKPNGRTVEVAEGEAVRtPQsVtAKQPPEIDKKNEKSK |
| Q86UY5 | S353 | Sugiyama | FAM83A TSGP | NPFSGRSAGSHPGTRsVsAssGPCsPAAPHPPPPPRFQPHQ |
| Q86VP6 | S376 | Sugiyama | CAND1 KIAA0829 TIP120 TIP120A | CLDAVVSTRHEMLPEFyKTVsPALISRFKEREENVKADVFH |
| Q86VQ1 | T350 | Sugiyama | GLCCI1 | RRAPLPAHYRssstRsIDTQtPsVQERSSSCSSHSPCVSPF |
| Q86VS8 | S238 | Sugiyama | HOOK3 | AENQVLMERLNQsDsIEDPNsPAGRRHLQLQTQLEQLQEET |
| Q86W92 | S999 | Sugiyama | PPFIBP1 KIAA1230 | INNLTHMLKEDDMFKDFAARsPsAsItDEDsNV________ |
| Q86YP4 | S100 | Sugiyama | GATAD2A | DGPVDMRTSHSDMKSERRPPsPDVIVLsDNEQPssPRVNGL |
| Q86YP4 | S114 | Sugiyama | GATAD2A | SERRPPsPDVIVLsDNEQPssPRVNGLttVALKETSTEALM |
| Q8IV50 | S206 | Sugiyama | LYSMD2 | QIKLSTQAAKKLKEESRDEEsPyAtSLyHs___________ |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IX90 | S155 | Sugiyama | SKA3 C13orf3 RAMA1 | KDDLsDPPVASSCISEKsPRsPQLsDFGLERYIVSQVLPNP |
| Q8N1F7 | S430 | Sugiyama | NUP93 KIAA0095 | TEDYLWLKLNQVCFDDDGTssPQDRLTLsQFQKQLLEDYGE |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | S44 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | NGQATSMVQLQGGRFLMGtNsPDSRDGDGPVREATVKPFAI |
| Q8NBJ7 | T278 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | IDtADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPP |
| Q8ND56 | S300 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GRFGIRRDGPMKFEKDFDFEsANAQFNKEEIDREFHNKLKL |
| Q8NE71 | S22 | Sugiyama | ABCF1 ABC50 | PKAPKQQPPEPEWIGDGEstsPsDKVVKKGKKDKKIKKTFF |
| Q8NEY1 | S1000 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PsPPALPMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEA |
| Q8NEY1 | T1002 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | PPALPMSLSAKGQLTNIVsPtAAttPRITRsNsIPTHEAAF |
| Q8NEZ2 | S18 | Sugiyama | VPS37A HCRP1 | ___MSWLFPLTKsAsssAAGsPGGLTSLQQQKQRLIESLRN |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TB72 | S82 | Sugiyama | PUM2 KIAA0235 PUMH2 | MVQRRsGQGFHGNsEVNAILsPRsEsGGLGVsMVEYVLsss |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8TC07 | T689 | Sugiyama | TBC1D15 | SGARNDsPtQIPVssDVCRLtPA__________________ |
| Q8TCS8 | T757 | Sugiyama | PNPT1 PNPASE | GRDPADGRMRLSRKVLQsPAtTVVRTLNDRssIVMGEPIsQ |
| Q8TD19 | S868 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | LQGLKVAsEAPLEHKPQVEAssPRLNPAVtCAGKGtPLtPP |
| Q8WUF5 | S567 | Sugiyama | PPP1R13L IASPP NKIP1 PPP1R13BL RAI | ISRLFHRHGGPGPGGPEPELsPItEGSEARAGPPAPAPPAP |
| Q8WWM7 | S111 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PGAAAIGsARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVV |
| Q8WWM7 | S558 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | KRFQLEELRKFGAQFKLQPsssPENsLDPFPPRILKEEPKG |
| Q8WWM7 | S594 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | EEPKGKEKEVDGLLtsEPMGsPVssKtEsVsDKEDKPPLAP |
| Q8WX93 | S484 | Sugiyama | PALLD KIAA0992 CGI-151 | VRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAEPEEIC |
| Q8WXI9 | S122 | Sugiyama | GATAD2B KIAA1150 | DEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRM |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q92576 | S1614 | Sugiyama | PHF3 KIAA0244 | KRQLQEDQENNLQDNQtsNssPCRsNVGKGNIDGNVsCsEN |
| Q92598 | T795 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | DQDPVVRAQEIKTKIKELNNtCEPVVTQPKPKIEsPKLERt |
| Q92609 | S539 | Sugiyama | TBC1D5 KIAA0210 | KsEsMPVQLNKGLSSKNIsssPsVEsLPGGREFtGsPPssA |
| Q92615 | S664 | Sugiyama | LARP4B KIAA0217 LARP5 | ELRKPSYAEICQRTSKEPPssPLQPQKEQKPNTVGCGKEEK |
| Q92625 | S634 | Sugiyama | ANKS1A ANKS1 KIAA0229 ODIN | KAELKLsRsLsKsDsDLLtCsPtEDAtMGsRsEsLsNCsIG |
| Q92871 | S242 | Sugiyama | PMM1 PMMH22 | PGGNDFEIFADPRTVGHSVVsPQDtVQRCREIFFPETAHEA |
| Q92879 | S179 | Sugiyama | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | AMAQTAIKAMHQAQtMEGCssPMVVKFADTQKDKEQKRMAQ |
| Q92945 | S181 | Sugiyama | KHSRP FUBP2 | GRGGEQINKIQQDSGCKVQIsPDsGGLPERsVsLtGAPEsV |
| Q92973 | S111 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | FPNGVTDFIKSECLNNIGDSsPLIRATVGILITTIASKGEL |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q92993 | T158 | PSP | KAT5 HTATIP TIP60 | SCLQPNHRSTKRKVEVVsPAtPVPSETAPASVFPQNGAARR |
| Q969R5 | S683 | Sugiyama | L3MBTL2 | EPVPGEIIAVRVKEEHLDVAsPDKAssPELPVsVENIKQET |
| Q96B36 | S211 | Sugiyama | AKT1S1 PRAS40 | WGFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAE |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96CT7 | S207 | Sugiyama | CCDC124 | ENPNMRLsQLKQLLKKEWLRsPDNPMNQRAVPFNAPK____ |
| Q96D15 | T72 | Sugiyama | RCN3 UNQ239/PRO272 | FQYDHEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGD |
| Q96EK9 | S184 | Sugiyama | KTI12 SBBI81 | GSAQADVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFy |
| Q96HE7 | S173 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | LQWTKHDDSSDNFCEADDIQsPEAEyVDLLLNPERYTGYKG |
| Q96KB5 | T320 | Sugiyama | PBK TOPK | CtNEDPKDRPsAAHIVEALEtDV__________________ |
| Q96L14 | S238 | Sugiyama | CEP170P1 CEP170L KIAA0470L | PSAMLPsPPKQKssPVNNHHsPGQtPtLGQPEARALHPAAV |
| Q96L14 | T242 | Sugiyama | CEP170P1 CEP170L KIAA0470L | LPsPPKQKssPVNNHHsPGQtPtLGQPEARALHPAAVSAAA |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96S55 | T87 | Sugiyama | WRNIP1 WHIP | PGAKRRRLsEssALKQPAtPtAAEssEGEGEEGDDGGETES |
| Q96ST3 | T161 | Sugiyama | SIN3A | PQVYNDFLDIMKEFKSQsIDtPGVISRVSQLFKGHPDLIMG |
| Q99733 | S53 | Sugiyama | NAP1L4 NAP2 | QNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQL |
| Q99733 | T51 | Sugiyama | NAP1L4 NAP2 | VMQNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALK |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BQG0 | S11 | Sugiyama | MYBBP1A P160 | __________MEsRDPAQPMsPGEAtQsGARPADRYGLLKH |
| Q9BQG0 | T1161 | Sugiyama | MYBBP1A P160 | TLGVQRPKLEKKDAKEIPsAtQsPIsKKRKKKGFLPETKKR |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BTC0 | T1469 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | CADVRRNsVERPAEPVAGAAtPsLVEQQKMLEELNKQIEEQ |
| Q9BV73 | S2229 | Sugiyama | CEP250 CEP2 CNAP1 | QRLQDELELTRRALEKERLHsPGAtsTAELGSRGEQGVQLG |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BXP5 | S493 | Sugiyama | SRRT ARS2 ASR2 | VNIKEICWNLQNIRLRECELsPGVNRDLTRRVRNINGITQH |
| Q9BYG3 | S230 | Sugiyama | NIFK MKI67IP NOPP34 | LRKKKKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVA |
| Q9BYG3 | T234 | Sugiyama | NIFK MKI67IP NOPP34 | KKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELND |
| Q9BYG3 | T238 | Sugiyama | NIFK MKI67IP NOPP34 | sGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELNDDDKD |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZK7 | S451 | Sugiyama | TBL1XR1 IRA1 TBLR1 | RGICIHTLTKHQEPVysVAFsPDGRYLASGSFDKCVHIWNT |
| Q9C000 | S107 | PSP | NLRP1 CARD7 DEFCAP KIAA0926 NAC NALP1 | QEGAGHSPSFPYSPSEPHLGsPSQPTSTAVLMPWIHELPAG |
| Q9C0C2 | S1297 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GQADWtPDLGLRNMAPGAVCsPGEsKELGVGQMDWGNNLGL |
| Q9C0C2 | S1385 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | HGVGGVsQCPEPGLRHNGsLsPGLEARDPLEARELGVGETS |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S601 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LPLQQAEERyEsQEPLAGQEsPLPLATREAALPILEPVLGQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S712 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | PPPsGGGARRGAGAELKDtQsPstCsEGLLGWsQKDLQSEF |
| Q9GZV4 | S75 | Sugiyama | EIF5A2 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDYQLICIQ |
| Q9GZV4 | T76 | Sugiyama | EIF5A2 | VHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDYQLICIQD |
| Q9H0B6 | S445 | Sugiyama | KLC2 | RRDsAPyGEyGsWYKACKVDsPtVNTTLRSLGALYRRQGKL |
| Q9H0L4 | S344 | Sugiyama | CSTF2T KIAA0689 | LPPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPM |
| Q9H2C0 | S52 | Sugiyama | GAN GAN1 KLHL16 | AHLVLDGEEIPVQKNILAAAsPYIRTKLNYNPPKDDGSTYK |
| Q9H3K6 | T76 | Sugiyama | BOLA2 BOLA2A My016; BOLA2B | VNACLAEELPHIHAFEQKTLtPDQWARERQK__________ |
| Q9H488 | S264 | Sugiyama | POFUT1 FUT12 KIAA0180 | DWKNACAMLKDGTAGSHFMAsPQCVGySRSTAAPLTMTMCL |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H4G0 | S544 | Sugiyama | EPB41L1 KIAA0338 | KLIHRDRDWERERRLPssPAsPsPKGtPEKANERAGLREGs |
| Q9H501 | S198 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | DssLEEKQRTLDsGtSEIVKsPRIECSKTRREMQSVVQLIM |
| Q9H6F5 | S102 | Sugiyama | CCDC86 CYCLON | QGQPEPGAAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSE |
| Q9H6F5 | S110 | Sugiyama | CCDC86 CYCLON | AsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQD |
| Q9H6F5 | S113 | Sugiyama | CCDC86 CYCLON | QRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQDQGV |
| Q9H773 | S26 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GEIRGDTGGEDTAAPGRFsFsPEPTLEDIRRLHAEFAAERD |
| Q9H773 | S85 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GELAELFQWKTDGEPGPQGWsPRERAALQEELSDVLIYLVA |
| Q9H7P9 | S1049 | Sugiyama | PLEKHG2 | DFTVSVTTPVPKQEGHLDsEsPTNIPLTKQGGSRDVQGPDP |
| Q9H7P9 | S1261 | Sugiyama | PLEKHG2 | GGSLASHVARLEssDLtPPHsPPPSSRQLLGPNAAALSRYL |
| Q9H8Y8 | T222 | Sugiyama | GORASP2 GOLPH6 | IPTRPFEEGKKIsLPGQMAGtPItPLKDGFTEVQLSSVNPP |
| Q9H8Y8 | T225 | Sugiyama | GORASP2 GOLPH6 | RPFEEGKKIsLPGQMAGtPItPLKDGFTEVQLSSVNPPSLS |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9HAU0 | S930 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | RRHQQACLREKKKGLNVIGAsDQsPLQsPsNLRDNPFRTTQ |
| Q9HAU0 | S933 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | QQACLREKKKGLNVIGAsDQsPLQsPsNLRDNPFRTTQTRR |
| Q9HAU0 | S937 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | LREKKKGLNVIGAsDQsPLQsPsNLRDNPFRTTQTRRRDDK |
| Q9HC35 | S146 | Sugiyama | EML4 C2orf2 EMAPL4 | REKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsKNA |
| Q9HC38 | T242 | Sugiyama | GLOD4 C17orf25 CGI-150 My027 | PQKELPDLEDLMKRENQKILtPLVsLDtPGKATVQVVILAD |
| Q9HC38 | T249 | Sugiyama | GLOD4 C17orf25 CGI-150 My027 | LEDLMKRENQKILtPLVsLDtPGKATVQVVILADPDGHEIC |
| Q9HDC9 | S188 | Sugiyama | APMAP C20orf3 UNQ1869/PRO4305 | AYKGLFEVNPWKREVKLLLSsEtPIEGKNMSFVNDLTVTQD |
| Q9NPI6 | S523 | Sugiyama | DCP1A SMIF | APSVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILS |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQR4 | S133 | Sugiyama | NIT2 CUA002 | IHLFDIDVPGKITFQESKTLsPGDsFSTFDTPyCRVGLGIC |
| Q9NQW6 | S323 | Sugiyama | ANLN | ITDAKsCEGQNPELLPKtPIsPLKtGVSKPIVKsTLsQtVP |
| Q9NQW6 | T320 | Sugiyama | ANLN | TTSITDAKsCEGQNPELLPKtPIsPLKtGVSKPIVKsTLsQ |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NW68 | S232 | Sugiyama | BSDC1 UNQ2494/PRO5781 | EQsISEEPGWEEEEEELMGIsPIsPKEAKVPVAKISTFPEG |
| Q9NW68 | S235 | Sugiyama | BSDC1 UNQ2494/PRO5781 | ISEEPGWEEEEEELMGIsPIsPKEAKVPVAKISTFPEGEPG |
| Q9NWS0 | T195 | Sugiyama | PIH1D1 NOP17 | sQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWLE |
| Q9NY27 | T173 | Sugiyama | PPP4R2 SBBI57 | VMFPGNsPsytERSNINGPGtPRPLNRPKVsLSAPMTTNGL |
| Q9NYB0 | S203 | Sugiyama | TERF2IP DRIP5 RAP1 PP8000 | RYLKHLRGQEHKyLLGDAPVsPssQKLKRKAEEDPEAADsG |
| Q9NYF8 | S290 | Sugiyama | BCLAF1 BTF KIAA0164 | ERsGsGsVGNGssRysPsQNsPIHHIPsRRsPAKtIAPQNA |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9NZT2 | S378 | Sugiyama | OGFR | LERsQGDEAGGHGEDRPEPLsPKEsKKRKLELSRREQPPTE |
| Q9NZV1 | S184 | Sugiyama | CRIM1 S52 UNQ1886/PRO4330 | LKRIEEEKPDCSKARCEVQFsPRCPEDSVLIEGYAPPGECC |
| Q9P0K7 | S281 | Sugiyama | RAI14 KIAA1334 NORPEG | KIsSERSGTPKKRKAPPPPIsPtQLsDVssPRsItstPLsG |
| Q9P0K7 | S290 | Sugiyama | RAI14 KIAA1334 NORPEG | PKKRKAPPPPIsPtQLsDVssPRsItstPLsGKEsVFFAEP |
| Q9P265 | S134 | Sugiyama | DIP2B KIAA1463 | HKEQKMALPMPTKRRSTFVQsPADACtPPDtssAsEDEGsL |
| Q9UGP4 | S421 | Sugiyama | LIMD1 | CKEGPLGWSSDGsLGsVLLDsPssPRVRLPCQPLVPGPELR |
| Q9UGP4 | S423 | Sugiyama | LIMD1 | EGPLGWSSDGsLGsVLLDsPssPRVRLPCQPLVPGPELRPS |
| Q9UGP4 | S424 | Sugiyama | LIMD1 | GPLGWSSDGsLGsVLLDsPssPRVRLPCQPLVPGPELRPSA |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UHD1 | S110 | Sugiyama | CHORDC1 CHP1 | PKFQEHIIQAPKPVEAIKRPsPDEPMtNLELKISAsLKQAL |
| Q9UHD1 | T116 | Sugiyama | CHORDC1 CHP1 | IIQAPKPVEAIKRPsPDEPMtNLELKISAsLKQALDKLKLs |
| Q9UHI6 | T705 | Sugiyama | DDX20 DP103 GEMIN3 | sEstPVDDRIsLEQPPNGsDtPNPEKyQEsPGIQMKTRLKE |
| Q9UHL4 | S213 | Sugiyama | DPP7 DPP2 QPP | AGLGDSNQFFRDVTADFEGQsPKCTQGVREAFRQIKDLFLQ |
| Q9UI10 | T86 | Sugiyama | EIF2B4 EIF2BD | AAQCQVGPTRELPESGIQLGtPREKVPAGRSKAELRAERRA |
| Q9UJF2 | S663 | Sugiyama | RASAL2 NGAP | ssGLQKIFEDPTDSDLHKLKsPsQDNTDSYFRGKTLLLVQQ |
| Q9UKS6 | S341 | Sugiyama | PACSIN3 | DEVtLtsIVPTRDGTAPPPQsPGsPGtGQDEEWsDEEsPRK |
| Q9UKS6 | S344 | Sugiyama | PACSIN3 | tLtsIVPTRDGTAPPPQsPGsPGtGQDEEWsDEEsPRKAAT |
| Q9UKV3 | S365 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEARKSHLARQQQEKEMKttsPLEEEEREIKssQGLKEKsK |
| Q9UKX7 | S221 | Sugiyama | NUP50 NPAP60L PRO1146 | HGNsGRNsESEsNKVAAEtQsPsLFGstKLQQEStFLFHGN |
| Q9ULD2 | S1264 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | RsPtssAIPLQsPRNsGsFPsPsIsPR______________ |
| Q9ULD2 | S1266 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | PtssAIPLQsPRNsGsFPsPsIsPR________________ |
| Q9ULD2 | S1268 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ssAIPLQsPRNsGsFPsPsIsPR__________________ |
| Q9UNE7 | S23 | Sugiyama | STUB1 CHIP PP1131 | GKEEKEGGARLGAGGGsPEKsPsAQELKEQGNRLFVGRKYP |
| Q9UNX3 | S32 | Sugiyama | RPL26L1 RPL26P1 | sKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRKD |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPW0 | S223 | Sugiyama | FOXJ3 KIAA1041 | AINTVTNKVTLYNTDQDGsDsPRSSLNNSLSDQSLASVNLN |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1318 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | VPsMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGP |
| Q9UQ35 | S1329 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9UQ35 | S1404 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sELsPDAVEKAGMssNQsIssPVLDAVPRtPsRERsssAss |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2272 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tAVNLADsRtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtA |
| Q9UQ35 | S857 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFEssP |
| Q9UQ35 | S994 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPDtKVKPEtPPRQsHsGsIsPyPKVKAQtPPGPsLsGsKs |
| Q9UQ35 | T1413 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | KAGMssNQsIssPVLDAVPRtPsRERsssAssPEMKDGLPR |
| Q9UQ35 | T866 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sGtPPRQGsItsPQANEQsVtPQRRsCFEssPDPELKsRtP |
| Q9Y243 | T305 | Sugiyama | AKT3 PKBG | IKITDFGLCKEGITDAATMKtFCGtPEyLAPEVLEDNDyGR |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y2X7 | S362 | Sugiyama | GIT1 | TLIIDILSEAKRRQQGKsLssPtDNLELsLRSQSDLDDQHD |
| Q9Y3E2 | S45 | Sugiyama | BOLA1 CGI-143 | GSGAIGPVEAAIRTKLEEALsPEVLELRNESGGHAVPPGSE |
| Q9Y3E2 | S81 | Sugiyama | BOLA1 CGI-143 | PPGSETHFRVAVVssRFEGLsPLQRHRLVHAALAEELGGPV |
| Q9Y490 | S729 | Sugiyama | TLN1 KIAA1027 TLN | CALSTSQLVACTKVVAPtIssPVCQEQLVEAGRLVAKAVEG |
| Q9Y4E8 | S225 | Sugiyama | USP15 KIAA0529 | QGQVLVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPss |
| Q9Y4E8 | S229 | Sugiyama | USP15 KIAA0529 | LVIEQKNEDGtWPRGPstPKsPGAsNFstLPKIsPssLsNN |
| Q9Y5K6 | S542 | Sugiyama | CD2AP | PKEEDSANLKPSELKKDtCysPKPsVyLstPssAsKANTTA |
| Q9Y5K6 | Y548 | Sugiyama | CD2AP | ANLKPSELKKDtCysPKPsVyLstPssAsKANTTAFLtPLE |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y5T5 | S552 | Sugiyama | USP16 MSTP039 | TEEVDMKNINMDNDLEVLtssPtRNLNGAYLTEGSNGEVDI |
| Q9Y6G9 | S207 | Sugiyama | DYNC1LI1 DNCLI1 | EQKLIRDFQEyVEPGEDFPAsPQRRNtAsQEDKDDsVVLPL |
| Q9Y6G9 | S516 | Sugiyama | DYNC1LI1 DNCLI1 | HAELDRITRKPVtVsPttPtsPtEGEAs_____________ |
| Q9Y6G9 | T513 | Sugiyama | DYNC1LI1 DNCLI1 | LDVHAELDRITRKPVtVsPttPtsPtEGEAs__________ |
| Q9Y6G9 | T515 | Sugiyama | DYNC1LI1 DNCLI1 | VHAELDRITRKPVtVsPttPtsPtEGEAs____________ |
| Q9Y6M1 | S162 | Sugiyama | IGF2BP2 IMP2 VICKZ2 | GHQFENYsFKISYIPDEEVssPsPPQRAQRGDHSSREQGHA |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.998251e-08 | 7.398 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.148962e-08 | 7.211 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.541692e-08 | 7.184 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.458967e-07 | 6.609 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.518161e-06 | 5.819 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.620617e-06 | 5.582 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.820316e-06 | 5.317 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.219123e-05 | 4.914 | 1 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.436750e-05 | 4.129 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.356492e-05 | 4.029 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.841792e-05 | 4.007 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.074714e-04 | 3.969 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.142832e-04 | 3.942 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.357363e-04 | 3.867 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.472865e-04 | 3.832 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.704490e-04 | 3.768 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.696636e-04 | 3.770 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.081366e-04 | 3.682 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.367389e-04 | 3.626 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.743216e-04 | 3.562 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.646739e-04 | 3.577 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.710279e-04 | 3.567 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.693447e-04 | 3.570 | 1 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.778292e-04 | 3.556 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.085544e-04 | 3.511 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.085544e-04 | 3.511 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.084295e-04 | 3.511 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.474276e-04 | 3.459 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.998286e-04 | 3.398 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.998286e-04 | 3.398 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.785220e-04 | 3.422 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.839328e-04 | 3.416 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.889334e-04 | 3.410 | 1 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.000449e-04 | 3.398 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.387697e-04 | 3.358 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.275988e-04 | 3.278 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.275988e-04 | 3.278 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.328703e-04 | 3.199 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.752889e-04 | 3.171 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.752889e-04 | 3.171 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.696402e-04 | 3.174 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.886949e-04 | 3.162 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.203851e-04 | 3.142 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.452624e-04 | 3.128 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.629244e-04 | 3.118 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.683644e-04 | 3.114 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.683644e-04 | 3.114 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.200652e-04 | 3.086 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.897980e-04 | 3.051 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.434538e-04 | 3.025 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.837422e-04 | 3.007 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.171918e-03 | 2.931 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.084704e-03 | 2.965 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.130966e-03 | 2.947 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.112902e-03 | 2.954 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.104628e-03 | 2.957 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.087582e-03 | 2.964 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.167289e-03 | 2.933 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.167289e-03 | 2.933 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.138484e-03 | 2.944 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.225806e-03 | 2.912 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.331655e-03 | 2.876 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.421537e-03 | 2.847 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.443265e-03 | 2.841 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.455377e-03 | 2.837 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.548450e-03 | 2.810 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.695392e-03 | 2.771 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.823593e-03 | 2.739 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.147464e-03 | 2.668 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.147464e-03 | 2.668 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.426061e-03 | 2.615 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.293202e-03 | 2.640 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.381586e-03 | 2.623 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.171418e-03 | 2.663 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.260013e-03 | 2.646 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.356846e-03 | 2.628 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.457663e-03 | 2.609 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.636548e-03 | 2.579 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.718843e-03 | 2.566 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.949267e-03 | 2.530 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.949267e-03 | 2.530 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.877668e-03 | 2.541 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.877668e-03 | 2.541 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.818358e-03 | 2.550 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.325473e-03 | 2.478 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.386236e-03 | 2.470 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.427720e-03 | 2.465 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.486673e-03 | 2.458 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.562733e-03 | 2.448 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.609952e-03 | 2.442 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.039601e-03 | 2.394 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.039601e-03 | 2.394 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.174878e-03 | 2.379 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.192301e-03 | 2.378 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.192301e-03 | 2.378 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.222186e-03 | 2.374 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.606997e-03 | 2.337 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.614708e-03 | 2.336 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.592926e-03 | 2.338 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.592926e-03 | 2.338 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.049701e-03 | 2.297 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.590365e-03 | 2.253 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.997433e-03 | 2.222 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.003012e-03 | 2.222 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.067387e-03 | 2.217 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.077469e-03 | 2.216 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.131799e-03 | 2.147 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 7.131799e-03 | 2.147 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.243823e-03 | 2.140 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.243823e-03 | 2.140 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.265150e-03 | 2.083 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.064494e-03 | 2.151 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.064494e-03 | 2.151 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.064494e-03 | 2.151 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.064494e-03 | 2.151 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.064494e-03 | 2.151 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.155868e-03 | 2.089 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.097609e-03 | 2.149 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.011989e-03 | 2.154 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.930394e-03 | 2.159 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.531931e-03 | 2.123 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.040594e-03 | 2.152 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.164797e-03 | 2.145 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.985636e-03 | 2.098 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.040594e-03 | 2.152 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.155868e-03 | 2.089 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.196724e-03 | 2.086 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.609872e-03 | 2.119 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.265150e-03 | 2.083 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.685286e-03 | 2.061 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.251512e-03 | 2.034 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.689974e-03 | 2.014 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.024892e-02 | 1.989 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.050954e-02 | 1.978 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.061239e-02 | 1.974 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.063035e-02 | 1.973 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.113406e-02 | 1.953 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.141780e-02 | 1.942 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.142271e-02 | 1.942 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.148610e-02 | 1.940 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.258461e-02 | 1.900 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.359626e-02 | 1.867 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.359626e-02 | 1.867 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.353145e-02 | 1.869 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.386078e-02 | 1.858 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.350527e-02 | 1.869 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.388184e-02 | 1.858 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.408455e-02 | 1.851 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.408455e-02 | 1.851 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.413074e-02 | 1.850 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.436264e-02 | 1.843 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.436611e-02 | 1.843 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.464110e-02 | 1.834 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.504359e-02 | 1.823 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.504359e-02 | 1.823 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.644943e-02 | 1.784 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.618059e-02 | 1.791 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.647256e-02 | 1.783 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.504359e-02 | 1.823 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.504359e-02 | 1.823 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.611420e-02 | 1.793 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.743189e-02 | 1.759 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.768012e-02 | 1.753 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.820295e-02 | 1.740 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.845374e-02 | 1.734 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.860014e-02 | 1.730 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.864954e-02 | 1.729 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.905883e-02 | 1.720 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.925085e-02 | 1.716 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.948281e-02 | 1.710 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.972797e-02 | 1.705 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.081447e-02 | 1.682 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.081447e-02 | 1.682 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.139578e-02 | 1.670 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.143259e-02 | 1.669 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.195010e-02 | 1.659 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.512439e-02 | 1.600 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.409135e-02 | 1.618 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.409135e-02 | 1.618 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.289471e-02 | 1.640 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.233766e-02 | 1.651 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.224607e-02 | 1.653 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.461863e-02 | 1.609 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.601244e-02 | 1.585 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.605160e-02 | 1.584 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.822355e-02 | 1.549 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.007009e-02 | 1.522 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.019674e-02 | 1.520 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.090389e-02 | 1.510 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.172234e-02 | 1.499 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.221988e-02 | 1.492 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.260393e-02 | 1.487 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.260393e-02 | 1.487 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.271238e-02 | 1.485 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.283146e-02 | 1.484 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.283146e-02 | 1.484 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.344187e-02 | 1.476 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.371395e-02 | 1.472 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.378144e-02 | 1.471 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.384754e-02 | 1.470 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.403257e-02 | 1.468 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.562599e-02 | 1.448 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.562599e-02 | 1.448 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.562599e-02 | 1.448 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.562599e-02 | 1.448 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.562599e-02 | 1.448 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.854672e-02 | 1.414 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.854672e-02 | 1.414 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.804389e-02 | 1.420 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.804389e-02 | 1.420 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.774705e-02 | 1.423 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.055856e-02 | 1.392 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.774705e-02 | 1.423 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.804389e-02 | 1.420 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.844900e-02 | 1.415 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.537515e-02 | 1.451 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.117394e-02 | 1.385 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.192664e-02 | 1.378 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.192664e-02 | 1.378 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.192664e-02 | 1.378 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.346377e-02 | 1.362 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.359359e-02 | 1.361 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.362521e-02 | 1.360 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.496787e-02 | 1.347 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.496787e-02 | 1.347 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.542633e-02 | 1.343 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.625001e-02 | 1.335 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.667184e-02 | 1.331 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.832843e-02 | 1.316 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.901623e-02 | 1.310 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.994379e-02 | 1.222 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.994379e-02 | 1.222 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.994379e-02 | 1.222 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.802836e-02 | 1.236 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.802836e-02 | 1.236 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.802836e-02 | 1.236 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.802836e-02 | 1.236 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.246459e-02 | 1.280 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.645711e-02 | 1.248 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.827672e-02 | 1.235 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.825079e-02 | 1.235 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.599388e-02 | 1.252 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.130078e-02 | 1.290 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.827672e-02 | 1.235 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.010300e-02 | 1.300 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.127021e-02 | 1.290 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.825079e-02 | 1.235 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.682363e-02 | 1.245 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.580484e-02 | 1.253 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.451289e-02 | 1.264 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.038644e-02 | 1.298 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.067565e-02 | 1.217 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.067565e-02 | 1.217 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.067565e-02 | 1.217 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.067565e-02 | 1.217 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.194088e-02 | 1.208 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.194088e-02 | 1.208 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.194088e-02 | 1.208 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.194088e-02 | 1.208 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.289705e-02 | 1.201 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.298164e-02 | 1.201 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.447640e-02 | 1.191 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.493307e-02 | 1.188 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.665632e-02 | 1.176 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.665632e-02 | 1.176 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.696805e-02 | 1.174 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.734241e-02 | 1.172 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.742414e-02 | 1.171 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.062946e-02 | 1.151 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.281751e-02 | 1.138 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 7.290174e-02 | 1.137 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 7.290174e-02 | 1.137 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 7.290174e-02 | 1.137 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.290174e-02 | 1.137 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.303423e-02 | 1.136 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.303423e-02 | 1.136 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.303423e-02 | 1.136 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 8.574296e-02 | 1.067 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 8.574296e-02 | 1.067 | 0 | 0 |
| IRS activation | R-HSA-74713 | 8.574296e-02 | 1.067 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 8.574296e-02 | 1.067 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.118993e-02 | 1.090 | 0 | 0 |
| RSK activation | R-HSA-444257 | 8.118993e-02 | 1.090 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.118993e-02 | 1.090 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.118993e-02 | 1.090 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.995003e-02 | 1.046 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.995003e-02 | 1.046 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.995003e-02 | 1.046 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.995003e-02 | 1.046 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.995003e-02 | 1.046 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.958277e-02 | 1.099 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.958277e-02 | 1.099 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.958277e-02 | 1.099 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.958277e-02 | 1.099 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.929570e-02 | 1.101 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.129590e-02 | 1.040 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.788379e-02 | 1.109 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.788379e-02 | 1.109 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.907739e-02 | 1.102 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.490539e-02 | 1.071 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.846714e-02 | 1.053 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.568338e-02 | 1.067 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.995003e-02 | 1.046 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.770417e-02 | 1.110 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.450092e-02 | 1.128 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.874559e-02 | 1.052 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.796954e-02 | 1.108 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.796954e-02 | 1.108 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.990959e-02 | 1.046 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.456260e-02 | 1.127 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.129590e-02 | 1.040 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.568338e-02 | 1.067 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.129590e-02 | 1.040 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.778620e-02 | 1.057 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.548204e-02 | 1.122 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.468770e-02 | 1.127 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.205029e-02 | 1.036 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.292857e-02 | 1.032 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.292857e-02 | 1.032 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.600434e-02 | 1.018 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.631403e-02 | 1.016 | 1 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.915808e-02 | 1.004 | 1 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.918703e-02 | 1.004 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.019433e-01 | 0.992 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.024102e-01 | 0.990 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.030224e-01 | 0.987 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.030224e-01 | 0.987 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.036177e-01 | 0.985 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.074420e-01 | 0.969 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.079635e-01 | 0.967 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.079635e-01 | 0.967 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.087037e-01 | 0.964 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.087037e-01 | 0.964 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.093164e-01 | 0.961 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.093164e-01 | 0.961 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 1.093164e-01 | 0.961 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.093164e-01 | 0.961 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.130117e-01 | 0.947 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.134275e-01 | 0.945 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.134275e-01 | 0.945 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.150492e-01 | 0.939 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.153977e-01 | 0.938 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.153977e-01 | 0.938 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 1.153977e-01 | 0.938 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.153977e-01 | 0.938 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.160158e-01 | 0.935 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.167491e-01 | 0.933 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.180189e-01 | 0.928 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.180189e-01 | 0.928 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.192974e-01 | 0.923 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.232937e-01 | 0.909 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.367560e-01 | 0.864 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.367560e-01 | 0.864 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.367560e-01 | 0.864 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.367560e-01 | 0.864 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.681375e-01 | 0.774 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 1.681375e-01 | 0.774 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.681375e-01 | 0.774 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.291912e-01 | 0.889 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.291912e-01 | 0.889 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.512822e-01 | 0.820 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.512822e-01 | 0.820 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.270763e-01 | 0.896 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.270763e-01 | 0.896 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.270763e-01 | 0.896 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.405728e-01 | 0.852 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.405728e-01 | 0.852 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.655949e-01 | 0.781 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.655949e-01 | 0.781 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.585597e-01 | 0.800 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.592889e-01 | 0.798 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.555289e-01 | 0.808 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.326171e-01 | 0.877 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.421975e-01 | 0.847 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.263908e-01 | 0.898 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.460972e-01 | 0.835 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.638478e-01 | 0.786 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.592889e-01 | 0.798 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.438767e-01 | 0.842 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.403243e-01 | 0.853 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.482844e-01 | 0.829 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.438767e-01 | 0.842 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.603433e-01 | 0.795 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.432457e-01 | 0.844 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.438863e-01 | 0.842 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.263908e-01 | 0.898 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.291912e-01 | 0.889 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.455245e-01 | 0.837 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.398326e-01 | 0.854 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.567837e-01 | 0.805 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.555289e-01 | 0.808 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.461337e-01 | 0.835 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.652398e-01 | 0.782 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.509395e-01 | 0.821 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.326891e-01 | 0.877 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.326891e-01 | 0.877 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.326891e-01 | 0.877 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.272282e-01 | 0.895 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.270763e-01 | 0.896 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.398326e-01 | 0.854 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.489321e-01 | 0.827 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.263908e-01 | 0.898 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.407494e-01 | 0.852 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.407494e-01 | 0.852 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.263908e-01 | 0.898 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.272282e-01 | 0.895 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.512822e-01 | 0.820 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.326171e-01 | 0.877 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.596642e-01 | 0.797 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.318811e-01 | 0.880 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.535538e-01 | 0.814 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.555289e-01 | 0.808 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.712242e-01 | 0.766 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.726560e-01 | 0.763 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.751928e-01 | 0.756 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.779512e-01 | 0.750 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.798149e-01 | 0.745 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.817164e-01 | 0.741 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.817164e-01 | 0.741 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.817164e-01 | 0.741 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.817164e-01 | 0.741 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.817164e-01 | 0.741 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.830694e-01 | 0.737 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.837527e-01 | 0.736 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.837527e-01 | 0.736 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.837527e-01 | 0.736 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 1.837527e-01 | 0.736 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.837527e-01 | 0.736 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.837527e-01 | 0.736 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.843675e-01 | 0.734 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.876191e-01 | 0.727 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.877694e-01 | 0.726 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.877694e-01 | 0.726 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.877694e-01 | 0.726 | 1 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.890103e-01 | 0.724 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.912265e-01 | 0.718 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.937437e-01 | 0.713 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.940045e-01 | 0.712 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.548166e-01 | 0.594 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.548166e-01 | 0.594 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.548166e-01 | 0.594 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.548166e-01 | 0.594 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.548166e-01 | 0.594 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.548166e-01 | 0.594 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.210471e-01 | 0.656 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.210471e-01 | 0.656 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.210471e-01 | 0.656 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.210471e-01 | 0.656 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.210471e-01 | 0.656 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.210471e-01 | 0.656 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.567367e-01 | 0.448 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.567367e-01 | 0.448 | 0 | 0 |
| Defective SLC9A9 causes autism 16 (AUTS16) | R-HSA-5619052 | 3.567367e-01 | 0.448 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.567367e-01 | 0.448 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.567367e-01 | 0.448 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.567367e-01 | 0.448 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.567367e-01 | 0.448 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.567367e-01 | 0.448 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.567367e-01 | 0.448 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.567367e-01 | 0.448 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.567367e-01 | 0.448 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.750478e-01 | 0.561 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.750478e-01 | 0.561 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.750478e-01 | 0.561 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.750478e-01 | 0.561 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.211623e-01 | 0.655 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.211623e-01 | 0.655 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.211623e-01 | 0.655 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.114161e-01 | 0.675 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.114161e-01 | 0.675 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.114161e-01 | 0.675 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.599065e-01 | 0.585 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.599065e-01 | 0.585 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.288523e-01 | 0.483 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.288523e-01 | 0.483 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.288523e-01 | 0.483 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.288523e-01 | 0.483 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.288523e-01 | 0.483 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.288523e-01 | 0.483 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.288523e-01 | 0.483 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.288523e-01 | 0.483 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.288523e-01 | 0.483 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.288523e-01 | 0.483 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.447220e-01 | 0.352 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.447220e-01 | 0.352 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.447220e-01 | 0.352 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.447220e-01 | 0.352 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.447220e-01 | 0.352 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.447220e-01 | 0.352 | 0 | 0 |
| Defective F8 sulfation at Y1699 | R-HSA-9674519 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.447220e-01 | 0.352 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.447220e-01 | 0.352 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.447220e-01 | 0.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.447220e-01 | 0.352 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.447220e-01 | 0.352 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.996519e-01 | 0.700 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.423475e-01 | 0.616 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.994278e-01 | 0.524 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.994278e-01 | 0.524 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 2.994278e-01 | 0.524 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.742076e-01 | 0.562 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.742076e-01 | 0.562 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.815046e-01 | 0.419 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.815046e-01 | 0.419 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.815046e-01 | 0.419 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.524391e-01 | 0.598 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.392270e-01 | 0.470 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.392270e-01 | 0.470 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.164524e-01 | 0.665 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.067039e-01 | 0.513 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.067039e-01 | 0.513 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.067039e-01 | 0.513 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.800282e-01 | 0.553 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.573520e-01 | 0.589 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.202215e-01 | 0.657 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.788668e-01 | 0.422 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.788668e-01 | 0.422 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.788668e-01 | 0.422 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.788668e-01 | 0.422 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 4.323137e-01 | 0.364 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.323137e-01 | 0.364 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 4.323137e-01 | 0.364 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.323137e-01 | 0.364 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 4.323137e-01 | 0.364 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.323137e-01 | 0.364 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.323137e-01 | 0.364 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.206771e-01 | 0.283 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.206771e-01 | 0.283 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.206771e-01 | 0.283 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.206771e-01 | 0.283 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.206771e-01 | 0.283 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.206771e-01 | 0.283 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.206771e-01 | 0.283 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.206771e-01 | 0.283 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.206771e-01 | 0.283 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.206771e-01 | 0.283 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.206771e-01 | 0.283 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.366767e-01 | 0.473 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.592414e-01 | 0.586 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.725152e-01 | 0.429 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.046153e-01 | 0.516 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.179726e-01 | 0.379 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.179726e-01 | 0.379 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.195410e-01 | 0.658 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.758487e-01 | 0.559 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.653834e-01 | 0.437 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.979205e-01 | 0.526 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.979205e-01 | 0.526 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.979205e-01 | 0.526 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.328297e-01 | 0.633 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.581960e-01 | 0.446 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.053371e-01 | 0.392 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.807991e-01 | 0.318 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.807991e-01 | 0.318 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.807991e-01 | 0.318 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.807991e-01 | 0.318 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.807991e-01 | 0.318 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.464393e-01 | 0.608 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.863176e-01 | 0.543 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.029403e-01 | 0.519 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.378853e-01 | 0.471 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.562307e-01 | 0.341 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.562307e-01 | 0.341 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.227474e-01 | 0.374 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.098194e-01 | 0.387 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.098194e-01 | 0.387 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.786520e-01 | 0.422 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.335953e-01 | 0.477 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.991870e-01 | 0.399 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.355260e-01 | 0.361 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 4.697570e-01 | 0.328 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.697570e-01 | 0.328 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.933844e-01 | 0.307 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.266459e-01 | 0.278 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.266459e-01 | 0.278 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.862463e-01 | 0.232 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.862463e-01 | 0.232 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.862463e-01 | 0.232 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.862463e-01 | 0.232 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 5.862463e-01 | 0.232 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.086650e-01 | 0.389 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.197460e-01 | 0.377 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.610253e-01 | 0.336 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.537641e-01 | 0.343 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.292300e-01 | 0.276 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.292300e-01 | 0.276 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.821116e-01 | 0.418 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.065758e-01 | 0.295 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.065758e-01 | 0.295 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.053040e-01 | 0.392 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.314234e-01 | 0.275 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.696689e-01 | 0.244 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.696689e-01 | 0.244 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.811216e-01 | 0.318 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.049158e-01 | 0.297 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.334601e-01 | 0.273 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.210412e-01 | 0.283 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.636112e-01 | 0.249 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.636112e-01 | 0.249 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.608939e-01 | 0.251 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.608939e-01 | 0.251 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.406652e-01 | 0.267 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.596595e-01 | 0.252 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.596595e-01 | 0.252 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.596595e-01 | 0.252 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.596595e-01 | 0.252 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.595016e-01 | 0.252 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.628341e-01 | 0.250 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.851003e-01 | 0.233 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.417899e-01 | 0.355 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.325028e-01 | 0.478 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.816282e-01 | 0.235 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.816282e-01 | 0.235 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.816282e-01 | 0.235 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.172322e-01 | 0.663 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.242031e-01 | 0.372 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.995452e-01 | 0.700 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.403707e-01 | 0.619 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.403707e-01 | 0.619 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.319393e-01 | 0.365 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.103047e-01 | 0.677 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.353869e-01 | 0.271 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.081675e-01 | 0.511 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.511783e-01 | 0.454 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.583510e-01 | 0.446 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.098194e-01 | 0.387 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.355260e-01 | 0.361 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.824364e-01 | 0.235 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.114161e-01 | 0.675 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.573520e-01 | 0.589 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.081675e-01 | 0.511 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.395590e-01 | 0.469 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.237208e-01 | 0.281 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.941816e-01 | 0.306 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.636112e-01 | 0.249 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.179215e-01 | 0.662 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.423475e-01 | 0.616 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.395590e-01 | 0.469 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.970282e-01 | 0.401 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.824364e-01 | 0.235 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.742076e-01 | 0.562 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.802394e-01 | 0.420 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.941816e-01 | 0.306 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.232878e-01 | 0.651 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.180962e-01 | 0.286 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.197460e-01 | 0.377 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.306453e-01 | 0.275 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.562307e-01 | 0.341 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.730095e-01 | 0.564 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.347706e-01 | 0.629 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.599065e-01 | 0.585 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.524391e-01 | 0.598 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.319393e-01 | 0.365 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.696689e-01 | 0.244 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.306453e-01 | 0.275 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.986260e-01 | 0.525 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.524391e-01 | 0.598 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.952332e-01 | 0.305 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.824364e-01 | 0.235 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.579066e-01 | 0.589 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.121270e-01 | 0.506 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.164524e-01 | 0.665 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.277694e-01 | 0.484 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.635331e-01 | 0.439 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.292300e-01 | 0.276 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.696689e-01 | 0.244 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.696689e-01 | 0.244 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.608939e-01 | 0.251 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.232878e-01 | 0.651 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.270478e-01 | 0.644 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.110366e-01 | 0.292 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.195586e-01 | 0.377 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.978202e-01 | 0.704 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.978202e-01 | 0.704 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.276369e-01 | 0.369 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.211623e-01 | 0.655 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.179726e-01 | 0.379 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.941243e-01 | 0.404 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.986260e-01 | 0.525 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.862463e-01 | 0.232 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.045738e-01 | 0.393 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.333687e-01 | 0.632 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.667391e-01 | 0.331 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.697570e-01 | 0.328 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.204175e-01 | 0.376 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.390221e-01 | 0.622 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.101328e-01 | 0.678 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.598769e-01 | 0.585 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.592414e-01 | 0.586 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.592414e-01 | 0.586 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.053371e-01 | 0.392 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.697570e-01 | 0.328 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.398790e-01 | 0.357 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.996464e-01 | 0.700 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.234452e-01 | 0.651 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.498612e-01 | 0.456 | 1 | 1 |
| MTOR signalling | R-HSA-165159 | 4.537641e-01 | 0.343 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.191589e-01 | 0.496 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.526809e-01 | 0.597 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.750478e-01 | 0.561 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.599065e-01 | 0.585 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.447220e-01 | 0.352 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.447220e-01 | 0.352 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.742076e-01 | 0.562 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.202215e-01 | 0.657 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.395590e-01 | 0.469 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.395590e-01 | 0.469 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.070473e-01 | 0.513 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.725152e-01 | 0.429 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.209724e-01 | 0.656 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.537641e-01 | 0.343 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.010063e-01 | 0.300 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.920105e-01 | 0.308 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.314234e-01 | 0.275 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.193986e-01 | 0.284 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.077811e-01 | 0.682 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.403707e-01 | 0.619 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.232878e-01 | 0.651 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.202215e-01 | 0.657 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.931737e-01 | 0.307 | 1 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.848921e-01 | 0.545 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.559743e-01 | 0.449 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.720536e-01 | 0.326 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.392270e-01 | 0.470 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.063167e-01 | 0.514 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.266459e-01 | 0.278 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.565585e-01 | 0.341 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 3.070473e-01 | 0.513 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.724530e-01 | 0.242 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.325028e-01 | 0.478 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.724994e-01 | 0.326 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.210471e-01 | 0.656 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.210471e-01 | 0.656 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.333687e-01 | 0.632 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.292300e-01 | 0.276 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.636112e-01 | 0.249 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.567737e-01 | 0.448 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.188947e-01 | 0.496 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.348526e-01 | 0.629 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.188947e-01 | 0.496 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.558790e-01 | 0.449 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.243861e-01 | 0.489 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.815046e-01 | 0.419 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.511783e-01 | 0.454 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.592111e-01 | 0.252 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.610253e-01 | 0.336 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.558790e-01 | 0.449 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.783901e-01 | 0.555 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.266459e-01 | 0.278 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.448756e-01 | 0.264 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.436137e-01 | 0.464 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.453699e-01 | 0.263 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.080066e-01 | 0.682 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.053371e-01 | 0.392 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.511127e-01 | 0.346 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.010599e-01 | 0.300 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.393767e-01 | 0.621 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.796222e-01 | 0.237 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.991870e-01 | 0.399 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.970282e-01 | 0.401 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.523420e-01 | 0.598 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.409699e-01 | 0.618 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.968987e-01 | 0.304 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.541530e-01 | 0.451 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.548166e-01 | 0.594 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.210471e-01 | 0.656 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.567367e-01 | 0.448 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.567367e-01 | 0.448 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.567367e-01 | 0.448 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.750478e-01 | 0.561 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.211623e-01 | 0.655 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.599065e-01 | 0.585 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.447220e-01 | 0.352 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.447220e-01 | 0.352 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 4.447220e-01 | 0.352 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.815046e-01 | 0.419 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.524391e-01 | 0.598 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.395590e-01 | 0.469 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.323137e-01 | 0.364 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.206771e-01 | 0.283 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.206771e-01 | 0.283 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.807991e-01 | 0.318 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.807991e-01 | 0.318 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.807991e-01 | 0.318 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.562307e-01 | 0.341 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.266459e-01 | 0.278 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.266459e-01 | 0.278 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.862463e-01 | 0.232 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.862463e-01 | 0.232 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.696689e-01 | 0.244 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.696689e-01 | 0.244 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.148041e-01 | 0.288 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.690153e-01 | 0.570 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.582699e-01 | 0.588 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.284888e-01 | 0.277 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.340862e-01 | 0.476 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.653834e-01 | 0.437 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.320873e-01 | 0.479 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.600906e-01 | 0.585 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.790934e-01 | 0.320 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.998229e-01 | 0.523 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.432163e-01 | 0.265 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.432163e-01 | 0.265 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.260319e-01 | 0.371 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.081675e-01 | 0.511 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.368947e-01 | 0.473 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.255848e-01 | 0.647 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.114161e-01 | 0.675 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.511783e-01 | 0.454 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.266459e-01 | 0.278 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.353869e-01 | 0.271 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.859728e-01 | 0.313 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.228943e-01 | 0.282 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.990264e-01 | 0.399 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.739900e-01 | 0.427 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.392270e-01 | 0.470 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.862463e-01 | 0.232 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.696689e-01 | 0.244 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.164524e-01 | 0.665 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.098194e-01 | 0.387 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.903205e-01 | 0.310 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.157686e-01 | 0.381 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.815046e-01 | 0.419 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.067039e-01 | 0.513 | 1 | 1 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.933844e-01 | 0.307 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.266459e-01 | 0.278 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.266459e-01 | 0.278 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.862463e-01 | 0.232 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 5.696689e-01 | 0.244 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.177725e-01 | 0.498 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.596595e-01 | 0.252 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.347706e-01 | 0.629 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.643681e-01 | 0.333 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.581985e-01 | 0.446 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.610253e-01 | 0.336 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.148041e-01 | 0.288 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.378133e-01 | 0.359 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.314234e-01 | 0.275 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.567367e-01 | 0.448 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.815046e-01 | 0.419 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.206771e-01 | 0.283 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.653834e-01 | 0.437 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.933844e-01 | 0.307 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.266459e-01 | 0.278 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.862463e-01 | 0.232 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.292300e-01 | 0.276 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.696689e-01 | 0.244 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.312203e-01 | 0.480 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.081675e-01 | 0.511 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.065758e-01 | 0.295 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.696689e-01 | 0.244 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.815046e-01 | 0.419 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.417899e-01 | 0.355 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.292300e-01 | 0.276 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.872623e-01 | 0.542 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.968987e-01 | 0.304 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.202215e-01 | 0.657 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.323137e-01 | 0.364 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.179726e-01 | 0.379 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.266459e-01 | 0.278 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.862463e-01 | 0.232 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.862463e-01 | 0.232 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.862463e-01 | 0.232 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.608939e-01 | 0.251 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.142786e-01 | 0.289 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.908321e-01 | 0.408 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.862463e-01 | 0.232 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.227474e-01 | 0.374 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.098825e-01 | 0.293 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.667391e-01 | 0.331 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.893251e-01 | 0.230 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.893251e-01 | 0.230 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.893251e-01 | 0.230 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.952988e-01 | 0.225 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.962457e-01 | 0.225 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.964143e-01 | 0.224 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.964143e-01 | 0.224 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.964143e-01 | 0.224 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.964143e-01 | 0.224 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.050248e-01 | 0.218 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.065995e-01 | 0.217 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.097827e-01 | 0.215 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.097827e-01 | 0.215 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.097827e-01 | 0.215 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.097827e-01 | 0.215 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.097827e-01 | 0.215 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.097827e-01 | 0.215 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.244450e-01 | 0.205 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.269285e-01 | 0.203 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.275625e-01 | 0.202 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.275625e-01 | 0.202 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.275625e-01 | 0.202 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.292929e-01 | 0.201 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.315966e-01 | 0.200 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.334733e-01 | 0.198 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.334733e-01 | 0.198 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.334733e-01 | 0.198 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.419661e-01 | 0.192 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.422149e-01 | 0.192 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.427991e-01 | 0.192 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.427991e-01 | 0.192 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.428050e-01 | 0.192 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.428492e-01 | 0.192 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.428492e-01 | 0.192 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.428492e-01 | 0.192 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.428492e-01 | 0.192 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.428492e-01 | 0.192 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.428492e-01 | 0.192 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.428492e-01 | 0.192 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.428492e-01 | 0.192 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.428492e-01 | 0.192 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.428492e-01 | 0.192 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.428492e-01 | 0.192 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.428492e-01 | 0.192 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.428492e-01 | 0.192 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.428492e-01 | 0.192 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.428492e-01 | 0.192 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 6.428492e-01 | 0.192 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.428492e-01 | 0.192 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.428492e-01 | 0.192 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.448782e-01 | 0.191 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.469781e-01 | 0.189 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.469781e-01 | 0.189 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.469781e-01 | 0.189 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.469781e-01 | 0.189 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.469781e-01 | 0.189 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.469781e-01 | 0.189 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 6.469781e-01 | 0.189 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.469781e-01 | 0.189 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.469781e-01 | 0.189 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.563179e-01 | 0.183 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.570111e-01 | 0.182 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.570111e-01 | 0.182 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.570111e-01 | 0.182 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.570111e-01 | 0.182 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.580125e-01 | 0.182 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.611810e-01 | 0.180 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.611810e-01 | 0.180 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.611810e-01 | 0.180 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.624161e-01 | 0.179 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.626002e-01 | 0.179 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.649647e-01 | 0.177 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.677514e-01 | 0.175 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.685473e-01 | 0.175 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.730487e-01 | 0.172 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.763191e-01 | 0.170 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.782272e-01 | 0.169 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.813028e-01 | 0.167 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.813028e-01 | 0.167 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.813028e-01 | 0.167 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.813028e-01 | 0.167 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.813028e-01 | 0.167 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.813028e-01 | 0.167 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.813028e-01 | 0.167 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.813028e-01 | 0.167 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.813028e-01 | 0.167 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.813028e-01 | 0.167 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.813028e-01 | 0.167 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.825766e-01 | 0.166 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.847428e-01 | 0.164 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.847428e-01 | 0.164 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.850558e-01 | 0.164 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.882130e-01 | 0.162 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.882130e-01 | 0.162 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.882130e-01 | 0.162 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.914801e-01 | 0.160 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.914801e-01 | 0.160 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.917114e-01 | 0.160 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.917114e-01 | 0.160 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.917114e-01 | 0.160 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.917114e-01 | 0.160 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.917114e-01 | 0.160 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.917114e-01 | 0.160 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.917114e-01 | 0.160 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 6.917114e-01 | 0.160 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.917114e-01 | 0.160 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 6.917114e-01 | 0.160 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.917114e-01 | 0.160 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.917114e-01 | 0.160 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.917114e-01 | 0.160 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.917114e-01 | 0.160 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.917114e-01 | 0.160 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.917114e-01 | 0.160 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.925547e-01 | 0.160 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.925547e-01 | 0.160 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.940696e-01 | 0.159 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.945599e-01 | 0.158 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.989066e-01 | 0.156 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.991826e-01 | 0.155 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.997947e-01 | 0.155 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.107627e-01 | 0.148 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.107627e-01 | 0.148 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.107627e-01 | 0.148 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.128459e-01 | 0.147 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.128459e-01 | 0.147 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.128459e-01 | 0.147 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.128459e-01 | 0.147 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.128459e-01 | 0.147 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.128459e-01 | 0.147 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.139768e-01 | 0.146 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.139768e-01 | 0.146 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.139768e-01 | 0.146 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.139768e-01 | 0.146 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.149238e-01 | 0.146 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.191741e-01 | 0.143 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.191741e-01 | 0.143 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.299303e-01 | 0.137 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.299303e-01 | 0.137 | 1 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.329859e-01 | 0.135 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.331326e-01 | 0.135 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.333193e-01 | 0.135 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.338912e-01 | 0.134 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.338912e-01 | 0.134 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.338912e-01 | 0.134 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.338912e-01 | 0.134 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.338912e-01 | 0.134 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.338912e-01 | 0.134 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.338912e-01 | 0.134 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 7.338912e-01 | 0.134 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 7.338912e-01 | 0.134 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.338912e-01 | 0.134 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 7.338912e-01 | 0.134 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 7.338912e-01 | 0.134 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.350951e-01 | 0.134 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.350951e-01 | 0.134 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.350951e-01 | 0.134 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.352446e-01 | 0.134 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.352446e-01 | 0.134 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.352446e-01 | 0.134 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.361797e-01 | 0.133 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.370437e-01 | 0.133 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.417261e-01 | 0.130 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.417261e-01 | 0.130 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.417261e-01 | 0.130 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.417261e-01 | 0.130 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.417261e-01 | 0.130 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.442144e-01 | 0.128 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.442144e-01 | 0.128 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.447330e-01 | 0.128 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.523464e-01 | 0.124 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.552968e-01 | 0.122 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.562631e-01 | 0.121 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.562631e-01 | 0.121 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.562631e-01 | 0.121 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.562631e-01 | 0.121 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.562631e-01 | 0.121 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.577792e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.577792e-01 | 0.120 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.577792e-01 | 0.120 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.589666e-01 | 0.120 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.626067e-01 | 0.118 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.626067e-01 | 0.118 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.667642e-01 | 0.115 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.680815e-01 | 0.115 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.680815e-01 | 0.115 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.680815e-01 | 0.115 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.680815e-01 | 0.115 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.680815e-01 | 0.115 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.680815e-01 | 0.115 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.680815e-01 | 0.115 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.680815e-01 | 0.115 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.680815e-01 | 0.115 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.703021e-01 | 0.113 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.703021e-01 | 0.113 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.703021e-01 | 0.113 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.703021e-01 | 0.113 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.703021e-01 | 0.113 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.703021e-01 | 0.113 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.703021e-01 | 0.113 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.703021e-01 | 0.113 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.703021e-01 | 0.113 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.703021e-01 | 0.113 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.703021e-01 | 0.113 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.712025e-01 | 0.113 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.741552e-01 | 0.111 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.741552e-01 | 0.111 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.771455e-01 | 0.109 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.771455e-01 | 0.109 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.788662e-01 | 0.109 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.788662e-01 | 0.109 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.788662e-01 | 0.109 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.788662e-01 | 0.109 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.788662e-01 | 0.109 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.788662e-01 | 0.109 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.801731e-01 | 0.108 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.803233e-01 | 0.108 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.850392e-01 | 0.105 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.895946e-01 | 0.103 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.910145e-01 | 0.102 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.920621e-01 | 0.101 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.920621e-01 | 0.101 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.920621e-01 | 0.101 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.920621e-01 | 0.101 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.932844e-01 | 0.101 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.941558e-01 | 0.100 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.984165e-01 | 0.098 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.984165e-01 | 0.098 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.998327e-01 | 0.097 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 8.017328e-01 | 0.096 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 8.017328e-01 | 0.096 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.017328e-01 | 0.096 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.017328e-01 | 0.096 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 8.017328e-01 | 0.096 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.017328e-01 | 0.096 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.017328e-01 | 0.096 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.017328e-01 | 0.096 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.017328e-01 | 0.096 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 8.017328e-01 | 0.096 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.017328e-01 | 0.096 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.048142e-01 | 0.094 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.077593e-01 | 0.093 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.084107e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.096750e-01 | 0.092 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.138243e-01 | 0.089 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.138243e-01 | 0.089 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.138243e-01 | 0.089 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.138243e-01 | 0.089 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.138243e-01 | 0.089 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.164975e-01 | 0.088 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.164975e-01 | 0.088 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.191843e-01 | 0.087 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.287437e-01 | 0.082 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.288642e-01 | 0.082 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 8.288642e-01 | 0.082 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.288642e-01 | 0.082 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.288642e-01 | 0.082 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.288642e-01 | 0.082 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.288642e-01 | 0.082 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.288642e-01 | 0.082 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.288642e-01 | 0.082 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.288642e-01 | 0.082 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 8.288642e-01 | 0.082 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.298256e-01 | 0.081 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.298256e-01 | 0.081 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.321545e-01 | 0.080 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.326898e-01 | 0.080 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.331808e-01 | 0.079 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.331808e-01 | 0.079 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.331808e-01 | 0.079 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.331808e-01 | 0.079 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.331808e-01 | 0.079 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.335261e-01 | 0.079 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.335261e-01 | 0.079 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.335261e-01 | 0.079 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.335261e-01 | 0.079 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 8.335261e-01 | 0.079 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.335261e-01 | 0.079 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.370646e-01 | 0.077 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.383032e-01 | 0.077 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.383032e-01 | 0.077 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.485413e-01 | 0.071 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.485413e-01 | 0.071 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.512593e-01 | 0.070 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.513238e-01 | 0.070 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.513238e-01 | 0.070 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.513238e-01 | 0.070 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.513238e-01 | 0.070 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.513238e-01 | 0.070 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.513238e-01 | 0.070 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.513238e-01 | 0.070 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.513238e-01 | 0.070 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.517211e-01 | 0.070 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.517211e-01 | 0.070 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.517211e-01 | 0.070 | 1 | 1 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.522843e-01 | 0.069 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.522843e-01 | 0.069 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.522843e-01 | 0.069 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.522843e-01 | 0.069 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.522843e-01 | 0.069 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.522843e-01 | 0.069 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.522843e-01 | 0.069 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.522843e-01 | 0.069 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.522843e-01 | 0.069 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.522843e-01 | 0.069 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.522843e-01 | 0.069 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.522843e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.530514e-01 | 0.069 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.566981e-01 | 0.067 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.572268e-01 | 0.067 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.572268e-01 | 0.067 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.572268e-01 | 0.067 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.586406e-01 | 0.066 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.626553e-01 | 0.064 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.626553e-01 | 0.064 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.626553e-01 | 0.064 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.626553e-01 | 0.064 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.626553e-01 | 0.064 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.626553e-01 | 0.064 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.626553e-01 | 0.064 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.641819e-01 | 0.063 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.643678e-01 | 0.063 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.650192e-01 | 0.063 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.673694e-01 | 0.062 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.673694e-01 | 0.062 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.673694e-01 | 0.062 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.673694e-01 | 0.062 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.673694e-01 | 0.062 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.673694e-01 | 0.062 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.673694e-01 | 0.062 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.673694e-01 | 0.062 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.673694e-01 | 0.062 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.673694e-01 | 0.062 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.673694e-01 | 0.062 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.673694e-01 | 0.062 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.673990e-01 | 0.062 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.687847e-01 | 0.061 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.699287e-01 | 0.061 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.723632e-01 | 0.059 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.725004e-01 | 0.059 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.725004e-01 | 0.059 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.725004e-01 | 0.059 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.725004e-01 | 0.059 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 8.725004e-01 | 0.059 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.725004e-01 | 0.059 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.725004e-01 | 0.059 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.725004e-01 | 0.059 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.725004e-01 | 0.059 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.725004e-01 | 0.059 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.725004e-01 | 0.059 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.755992e-01 | 0.058 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.757338e-01 | 0.058 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.818091e-01 | 0.055 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.818091e-01 | 0.055 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.818091e-01 | 0.055 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.818091e-01 | 0.055 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.818091e-01 | 0.055 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.835976e-01 | 0.054 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.850536e-01 | 0.053 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.864252e-01 | 0.052 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.864252e-01 | 0.052 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.864252e-01 | 0.052 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.874488e-01 | 0.052 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.874488e-01 | 0.052 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.874488e-01 | 0.052 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.874488e-01 | 0.052 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.878415e-01 | 0.052 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.883356e-01 | 0.051 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.883356e-01 | 0.051 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.899508e-01 | 0.051 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.899508e-01 | 0.051 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.899508e-01 | 0.051 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.899508e-01 | 0.051 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.899508e-01 | 0.051 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.899508e-01 | 0.051 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.917068e-01 | 0.050 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.947818e-01 | 0.048 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.947818e-01 | 0.048 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.947818e-01 | 0.048 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.947818e-01 | 0.048 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.963044e-01 | 0.048 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.963044e-01 | 0.048 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.981313e-01 | 0.047 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.998954e-01 | 0.046 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.002507e-01 | 0.046 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.016508e-01 | 0.045 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.029310e-01 | 0.044 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.050138e-01 | 0.043 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 9.050138e-01 | 0.043 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.050138e-01 | 0.043 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 9.050138e-01 | 0.043 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 9.050138e-01 | 0.043 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 9.050138e-01 | 0.043 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.050138e-01 | 0.043 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 9.050138e-01 | 0.043 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.054191e-01 | 0.043 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.064186e-01 | 0.043 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.064186e-01 | 0.043 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.064186e-01 | 0.043 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.071099e-01 | 0.042 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.075467e-01 | 0.042 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.075467e-01 | 0.042 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.128974e-01 | 0.040 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.138163e-01 | 0.039 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.138163e-01 | 0.039 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.138163e-01 | 0.039 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.138163e-01 | 0.039 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.146869e-01 | 0.039 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.168420e-01 | 0.038 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.168420e-01 | 0.038 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.171621e-01 | 0.038 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 9.180157e-01 | 0.037 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.180157e-01 | 0.037 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 9.180157e-01 | 0.037 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.180157e-01 | 0.037 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.189477e-01 | 0.037 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.196306e-01 | 0.036 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.206153e-01 | 0.036 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.206153e-01 | 0.036 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.206153e-01 | 0.036 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.215417e-01 | 0.035 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.253524e-01 | 0.034 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.253524e-01 | 0.034 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.261660e-01 | 0.033 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.261660e-01 | 0.033 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.261660e-01 | 0.033 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.261660e-01 | 0.033 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.261660e-01 | 0.033 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.261660e-01 | 0.033 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.269163e-01 | 0.033 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.272692e-01 | 0.033 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.272692e-01 | 0.033 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.275379e-01 | 0.033 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.286395e-01 | 0.032 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.286395e-01 | 0.032 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.286395e-01 | 0.032 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.292385e-01 | 0.032 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.292385e-01 | 0.032 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.292385e-01 | 0.032 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.292385e-01 | 0.032 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.292385e-01 | 0.032 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.292385e-01 | 0.032 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.292385e-01 | 0.032 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.292385e-01 | 0.032 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.308850e-01 | 0.031 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.322927e-01 | 0.030 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.327935e-01 | 0.030 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.344964e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.344964e-01 | 0.029 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.344964e-01 | 0.029 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.344964e-01 | 0.029 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.344964e-01 | 0.029 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.344964e-01 | 0.029 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.351522e-01 | 0.029 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.351522e-01 | 0.029 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.386514e-01 | 0.027 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.386514e-01 | 0.027 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.389256e-01 | 0.027 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.389256e-01 | 0.027 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.389256e-01 | 0.027 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.389256e-01 | 0.027 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.389256e-01 | 0.027 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.389256e-01 | 0.027 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 9.389256e-01 | 0.027 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.389256e-01 | 0.027 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.389256e-01 | 0.027 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.389256e-01 | 0.027 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.389256e-01 | 0.027 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.391048e-01 | 0.027 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.395453e-01 | 0.027 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.395453e-01 | 0.027 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.409933e-01 | 0.026 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.411208e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.419303e-01 | 0.026 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.419303e-01 | 0.026 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.419303e-01 | 0.026 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.419303e-01 | 0.026 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.419303e-01 | 0.026 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.419303e-01 | 0.026 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.443474e-01 | 0.025 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.465843e-01 | 0.024 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.465843e-01 | 0.024 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.472871e-01 | 0.024 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.472871e-01 | 0.024 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.472871e-01 | 0.024 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.472871e-01 | 0.024 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.472871e-01 | 0.024 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.472871e-01 | 0.024 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.472871e-01 | 0.024 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.482206e-01 | 0.023 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.485570e-01 | 0.023 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.485570e-01 | 0.023 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.485570e-01 | 0.023 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.485570e-01 | 0.023 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.491786e-01 | 0.023 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.512026e-01 | 0.022 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.512026e-01 | 0.022 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.512026e-01 | 0.022 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.544582e-01 | 0.020 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.544582e-01 | 0.020 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.544582e-01 | 0.020 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.544582e-01 | 0.020 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.545042e-01 | 0.020 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.545042e-01 | 0.020 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.545042e-01 | 0.020 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.545042e-01 | 0.020 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.545042e-01 | 0.020 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.545042e-01 | 0.020 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.545042e-01 | 0.020 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.545042e-01 | 0.020 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.545042e-01 | 0.020 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.551144e-01 | 0.020 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.561419e-01 | 0.019 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.562105e-01 | 0.019 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.562105e-01 | 0.019 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.595182e-01 | 0.018 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.595636e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.597083e-01 | 0.018 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.597083e-01 | 0.018 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.597083e-01 | 0.018 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.607336e-01 | 0.017 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.607336e-01 | 0.017 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.607336e-01 | 0.017 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.607336e-01 | 0.017 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.607336e-01 | 0.017 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.607336e-01 | 0.017 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.607336e-01 | 0.017 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.614730e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.628672e-01 | 0.016 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.629715e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.639063e-01 | 0.016 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.640980e-01 | 0.016 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.643749e-01 | 0.016 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.643749e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.644300e-01 | 0.016 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.649213e-01 | 0.016 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.661103e-01 | 0.015 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.661103e-01 | 0.015 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.661103e-01 | 0.015 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.661103e-01 | 0.015 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.661103e-01 | 0.015 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.685432e-01 | 0.014 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.695874e-01 | 0.013 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.707511e-01 | 0.013 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.707511e-01 | 0.013 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.707511e-01 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.709797e-01 | 0.013 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.716068e-01 | 0.013 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.718065e-01 | 0.012 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.718065e-01 | 0.012 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.720334e-01 | 0.012 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.720334e-01 | 0.012 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.721970e-01 | 0.012 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.735502e-01 | 0.012 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.736308e-01 | 0.012 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.736308e-01 | 0.012 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.745151e-01 | 0.011 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.747566e-01 | 0.011 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.747566e-01 | 0.011 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.747566e-01 | 0.011 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.747566e-01 | 0.011 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.747566e-01 | 0.011 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.747566e-01 | 0.011 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.747874e-01 | 0.011 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.747874e-01 | 0.011 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.749618e-01 | 0.011 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.761433e-01 | 0.010 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.774672e-01 | 0.010 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.774672e-01 | 0.010 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.782138e-01 | 0.010 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.782138e-01 | 0.010 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.782138e-01 | 0.010 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.783477e-01 | 0.010 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.783477e-01 | 0.010 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.791435e-01 | 0.009 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.798743e-01 | 0.009 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.806283e-01 | 0.008 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.809063e-01 | 0.008 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.811976e-01 | 0.008 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.811976e-01 | 0.008 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.811976e-01 | 0.008 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.811976e-01 | 0.008 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.817195e-01 | 0.008 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.820347e-01 | 0.008 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.822542e-01 | 0.008 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.831704e-01 | 0.007 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.831704e-01 | 0.007 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.831704e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.831704e-01 | 0.007 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.831704e-01 | 0.007 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.837730e-01 | 0.007 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.837730e-01 | 0.007 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.837730e-01 | 0.007 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.837730e-01 | 0.007 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.839723e-01 | 0.007 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.839723e-01 | 0.007 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.839723e-01 | 0.007 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.843718e-01 | 0.007 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.847975e-01 | 0.007 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.853516e-01 | 0.006 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.858208e-01 | 0.006 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.859957e-01 | 0.006 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.859957e-01 | 0.006 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.859957e-01 | 0.006 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.859957e-01 | 0.006 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.867459e-01 | 0.006 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.867459e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.869424e-01 | 0.006 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.869908e-01 | 0.006 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.872638e-01 | 0.006 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.878942e-01 | 0.005 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.879141e-01 | 0.005 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.879141e-01 | 0.005 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.879141e-01 | 0.005 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.879141e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.879141e-01 | 0.005 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.882860e-01 | 0.005 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.886083e-01 | 0.005 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.887652e-01 | 0.005 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.895698e-01 | 0.005 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.895698e-01 | 0.005 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.895698e-01 | 0.005 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.895698e-01 | 0.005 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.895698e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.897727e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.897727e-01 | 0.004 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.899001e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.899077e-01 | 0.004 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.899077e-01 | 0.004 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.902138e-01 | 0.004 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.902138e-01 | 0.004 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.909949e-01 | 0.004 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.909987e-01 | 0.004 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.909987e-01 | 0.004 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.909987e-01 | 0.004 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.909987e-01 | 0.004 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.909987e-01 | 0.004 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.911034e-01 | 0.004 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.911034e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.911034e-01 | 0.004 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.911034e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.915217e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.915217e-01 | 0.004 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.915217e-01 | 0.004 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.920063e-01 | 0.003 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.921774e-01 | 0.003 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.921774e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.921774e-01 | 0.003 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.922040e-01 | 0.003 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.922320e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.922320e-01 | 0.003 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.922320e-01 | 0.003 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.922320e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.931242e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.931242e-01 | 0.003 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.932924e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.933659e-01 | 0.003 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.936848e-01 | 0.003 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.936848e-01 | 0.003 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.936848e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.937912e-01 | 0.003 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.938777e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.939585e-01 | 0.003 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.939585e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.939585e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.939585e-01 | 0.003 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.940025e-01 | 0.003 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.940025e-01 | 0.003 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.942096e-01 | 0.003 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.942149e-01 | 0.003 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.942149e-01 | 0.003 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.942149e-01 | 0.003 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.943298e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.943443e-01 | 0.002 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.943845e-01 | 0.002 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.943905e-01 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.946475e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.947003e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.947375e-01 | 0.002 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.950076e-01 | 0.002 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.950076e-01 | 0.002 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.950076e-01 | 0.002 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.950076e-01 | 0.002 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.950194e-01 | 0.002 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.953402e-01 | 0.002 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.955796e-01 | 0.002 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.955796e-01 | 0.002 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.955796e-01 | 0.002 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.956918e-01 | 0.002 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.956918e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.959095e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.959095e-01 | 0.002 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.960784e-01 | 0.002 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.961557e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.961597e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.962898e-01 | 0.002 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.964104e-01 | 0.002 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.965222e-01 | 0.002 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.966119e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.966792e-01 | 0.001 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.968508e-01 | 0.001 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.968508e-01 | 0.001 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.968508e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.969717e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.971003e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.972315e-01 | 0.001 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.972380e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.972380e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.972674e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.972674e-01 | 0.001 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.975343e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.975343e-01 | 0.001 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.975798e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.975798e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.975798e-01 | 0.001 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.976110e-01 | 0.001 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.976110e-01 | 0.001 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.976110e-01 | 0.001 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.976110e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.976409e-01 | 0.001 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.978569e-01 | 0.001 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.979385e-01 | 0.001 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.979385e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.979385e-01 | 0.001 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.979385e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.979385e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.980808e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.981395e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.981395e-01 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.981993e-01 | 0.001 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.982211e-01 | 0.001 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.982211e-01 | 0.001 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.982211e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.983048e-01 | 0.001 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.983211e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.983219e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.983718e-01 | 0.001 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.984650e-01 | 0.001 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.984650e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.984650e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.984650e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.984650e-01 | 0.001 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.985148e-01 | 0.001 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.985721e-01 | 0.001 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.985721e-01 | 0.001 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.985721e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.986754e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.986754e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.986754e-01 | 0.001 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.986754e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.986754e-01 | 0.001 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.987496e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.988387e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.988570e-01 | 0.000 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.989464e-01 | 0.000 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.990138e-01 | 0.000 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.990138e-01 | 0.000 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.990138e-01 | 0.000 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.990138e-01 | 0.000 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.991490e-01 | 0.000 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.991490e-01 | 0.000 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.992002e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.992881e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.992926e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.992926e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.993580e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.993664e-01 | 0.000 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.994034e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.994299e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.994385e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.994533e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.994533e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.995137e-01 | 0.000 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.995392e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.995392e-01 | 0.000 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.995797e-01 | 0.000 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.995930e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.995930e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.995930e-01 | 0.000 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.995938e-01 | 0.000 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.996125e-01 | 0.000 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.996217e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.996239e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.996248e-01 | 0.000 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.996248e-01 | 0.000 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.996488e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.996488e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.996970e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.996985e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.996985e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.997060e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.997060e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.997061e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.997744e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.997766e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.998090e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.998321e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998321e-01 | 0.000 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.998321e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.998441e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.998494e-01 | 0.000 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.998551e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.998736e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998796e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.998799e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.998842e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.998881e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998890e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.998921e-01 | 0.000 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.998931e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999031e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999065e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.999070e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.999070e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999155e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.999197e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.999308e-01 | 0.000 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.999357e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999357e-01 | 0.000 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.999393e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.999485e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999555e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.999568e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999630e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999707e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999715e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999715e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.999720e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.999743e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999754e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.999786e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999802e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999802e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999808e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999842e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.999842e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999847e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999866e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.999883e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999895e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999906e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.999906e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999912e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999912e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.999918e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.999929e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.999938e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.999953e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.999964e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999969e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.999969e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999969e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999972e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.999973e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.999973e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999977e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999979e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.999980e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999980e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999982e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999982e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999984e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.999984e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999987e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.999988e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999991e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999992e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999993e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999993e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999994e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999997e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999999e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999999e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 1 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 1 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 5.055956e-13 | 12.296 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.022016e-11 | 10.991 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.833419e-09 | 8.316 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.348702e-09 | 8.197 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.800226e-07 | 6.553 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.734079e-07 | 6.563 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.822853e-07 | 6.418 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.642321e-07 | 6.117 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.015434e-07 | 6.096 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.922004e-07 | 6.050 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.124259e-06 | 5.673 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.645908e-06 | 5.438 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.041434e-06 | 5.393 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.461713e-06 | 5.350 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.917433e-06 | 5.228 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.421088e-06 | 5.192 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.247219e-06 | 5.084 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.779945e-06 | 5.109 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.247219e-06 | 5.084 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.095933e-06 | 5.041 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.077202e-06 | 5.042 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.208924e-05 | 4.918 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.208924e-05 | 4.918 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.528998e-05 | 4.816 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.684788e-05 | 4.773 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.680189e-05 | 4.775 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.800481e-05 | 4.745 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.048548e-05 | 4.689 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.076747e-05 | 4.683 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.147556e-05 | 4.668 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.371143e-05 | 4.625 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.487515e-05 | 4.604 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.764513e-05 | 4.558 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.686765e-05 | 4.571 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.663963e-05 | 4.574 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.764513e-05 | 4.558 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.202034e-05 | 4.495 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.202034e-05 | 4.495 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.419028e-05 | 4.466 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.856933e-05 | 4.414 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.856933e-05 | 4.414 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.746088e-05 | 4.426 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.347355e-05 | 4.362 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.390845e-05 | 4.357 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.892136e-05 | 4.311 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.071354e-05 | 4.150 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.989246e-05 | 4.097 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.076615e-04 | 3.968 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.325854e-04 | 3.878 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.369168e-04 | 3.864 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.445297e-04 | 3.840 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.522228e-04 | 3.818 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.496391e-04 | 3.825 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.623271e-04 | 3.790 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.626870e-04 | 3.789 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.695285e-04 | 3.771 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.767372e-04 | 3.753 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.847192e-04 | 3.733 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.945908e-04 | 3.711 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.072250e-04 | 3.684 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.393190e-04 | 3.621 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.419436e-04 | 3.616 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.419436e-04 | 3.616 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.485676e-04 | 3.605 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.854707e-04 | 3.544 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.245643e-04 | 3.489 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.525462e-04 | 3.453 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.456128e-04 | 3.461 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.580217e-04 | 3.446 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.747510e-04 | 3.426 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.779948e-04 | 3.423 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.123328e-04 | 3.385 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.502698e-04 | 3.347 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.459438e-04 | 3.351 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.781762e-04 | 3.320 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.874326e-04 | 3.312 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.896807e-04 | 3.310 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.369294e-04 | 3.270 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.943114e-04 | 3.226 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.811575e-04 | 3.236 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.092896e-04 | 3.215 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.449059e-04 | 3.191 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.601566e-04 | 3.180 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.798113e-04 | 3.168 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.811956e-04 | 3.167 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.422516e-04 | 3.075 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.830870e-04 | 3.054 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.946112e-04 | 3.002 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.707998e-04 | 3.013 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.855906e-04 | 3.006 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.855906e-04 | 3.006 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.279055e-04 | 3.032 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.279055e-04 | 3.032 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.010173e-03 | 2.996 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.018373e-03 | 2.992 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.100620e-03 | 2.958 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.221509e-03 | 2.913 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.337323e-03 | 2.874 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.337323e-03 | 2.874 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.242625e-03 | 2.906 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.319090e-03 | 2.880 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.291383e-03 | 2.889 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.341581e-03 | 2.872 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.390849e-03 | 2.857 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.446427e-03 | 2.840 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.507392e-03 | 2.822 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.769113e-03 | 2.752 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.769113e-03 | 2.752 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.942206e-03 | 2.712 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.942206e-03 | 2.712 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.017529e-03 | 2.695 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.106544e-03 | 2.676 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.128949e-03 | 2.672 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.195095e-03 | 2.659 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.524949e-03 | 2.598 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.539893e-03 | 2.595 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.684026e-03 | 2.571 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.926416e-03 | 2.534 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.955223e-03 | 2.529 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.091389e-03 | 2.510 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.091389e-03 | 2.510 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.144915e-03 | 2.502 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.752364e-03 | 2.426 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.039127e-03 | 2.394 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.070389e-03 | 2.390 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.237814e-03 | 2.373 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.491455e-03 | 2.348 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.506839e-03 | 2.346 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.524329e-03 | 2.344 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.741352e-03 | 2.324 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.831436e-03 | 2.316 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.019186e-03 | 2.299 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.268125e-03 | 2.278 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.430125e-03 | 2.265 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.649064e-03 | 2.248 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.891432e-03 | 2.230 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.535460e-03 | 2.257 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.577498e-03 | 2.254 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.323248e-03 | 2.274 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.083217e-03 | 2.216 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.191822e-03 | 2.208 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.209461e-03 | 2.207 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.534278e-03 | 2.185 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.843572e-03 | 2.165 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.867164e-03 | 2.163 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.867164e-03 | 2.163 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.172667e-03 | 2.144 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 7.678197e-03 | 2.115 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 8.719244e-03 | 2.060 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.862565e-03 | 2.052 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.999845e-03 | 2.097 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.202261e-03 | 2.086 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.348597e-03 | 2.078 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.858848e-03 | 2.053 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.360504e-03 | 2.078 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.177999e-03 | 2.037 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.225647e-03 | 2.035 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.457139e-03 | 2.024 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.553389e-03 | 2.020 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.005300e-02 | 1.998 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.031679e-02 | 1.986 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.056193e-02 | 1.976 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.126613e-02 | 1.948 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.126613e-02 | 1.948 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.126613e-02 | 1.948 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.126613e-02 | 1.948 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.126613e-02 | 1.948 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.126613e-02 | 1.948 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.214069e-02 | 1.916 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.214069e-02 | 1.916 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.214069e-02 | 1.916 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.136647e-02 | 1.944 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.136647e-02 | 1.944 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.181582e-02 | 1.928 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.114724e-02 | 1.953 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.188297e-02 | 1.925 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.200732e-02 | 1.921 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.200732e-02 | 1.921 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.170560e-02 | 1.932 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.224778e-02 | 1.912 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.224778e-02 | 1.912 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.224778e-02 | 1.912 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.224778e-02 | 1.912 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.282213e-02 | 1.892 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.308248e-02 | 1.883 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.311030e-02 | 1.882 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.374509e-02 | 1.862 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.466931e-02 | 1.834 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.469273e-02 | 1.833 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.498925e-02 | 1.824 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.498925e-02 | 1.824 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.515804e-02 | 1.819 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.536621e-02 | 1.813 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.599848e-02 | 1.796 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.599848e-02 | 1.796 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.774917e-02 | 1.751 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.713032e-02 | 1.766 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.569706e-02 | 1.804 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.591745e-02 | 1.798 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.793746e-02 | 1.746 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.599848e-02 | 1.796 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.561031e-02 | 1.807 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.581497e-02 | 1.801 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.773835e-02 | 1.751 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.822525e-02 | 1.739 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.877056e-02 | 1.727 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.877056e-02 | 1.727 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.877056e-02 | 1.727 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.989734e-02 | 1.701 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.008286e-02 | 1.697 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.073427e-02 | 1.683 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.146167e-02 | 1.668 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.146167e-02 | 1.668 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.226664e-02 | 1.652 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.261594e-02 | 1.646 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.263952e-02 | 1.645 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.263952e-02 | 1.645 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.406941e-02 | 1.619 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.474616e-02 | 1.606 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.545781e-02 | 1.594 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.552451e-02 | 1.593 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.563627e-02 | 1.591 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.627388e-02 | 1.580 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.645658e-02 | 1.577 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.677911e-02 | 1.572 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.713446e-02 | 1.566 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.713446e-02 | 1.566 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.745573e-02 | 1.561 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.980974e-02 | 1.526 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.365272e-02 | 1.473 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.365272e-02 | 1.473 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.212119e-02 | 1.493 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.255796e-02 | 1.487 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.227936e-02 | 1.491 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.098045e-02 | 1.509 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.074735e-02 | 1.512 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.154239e-02 | 1.501 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.074735e-02 | 1.512 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.823996e-02 | 1.549 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.992224e-02 | 1.524 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.395532e-02 | 1.469 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.466325e-02 | 1.460 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.495705e-02 | 1.456 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.557814e-02 | 1.449 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.654519e-02 | 1.437 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.698053e-02 | 1.432 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.730801e-02 | 1.428 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.772993e-02 | 1.423 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.772993e-02 | 1.423 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.781169e-02 | 1.422 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.781169e-02 | 1.422 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.851496e-02 | 1.414 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.877244e-02 | 1.411 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.900133e-02 | 1.409 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.900133e-02 | 1.409 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.968161e-02 | 1.401 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.974118e-02 | 1.401 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.974118e-02 | 1.401 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.974118e-02 | 1.401 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.974118e-02 | 1.401 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.064485e-02 | 1.391 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.064485e-02 | 1.391 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.064485e-02 | 1.391 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.064485e-02 | 1.391 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.068068e-02 | 1.391 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.275922e-02 | 1.369 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.335770e-02 | 1.363 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.374057e-02 | 1.359 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.387025e-02 | 1.358 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.573582e-02 | 1.340 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.610626e-02 | 1.336 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.610626e-02 | 1.336 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.610626e-02 | 1.336 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 6.034534e-02 | 1.219 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.799039e-02 | 1.237 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.774569e-02 | 1.238 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.697636e-02 | 1.244 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.137368e-02 | 1.212 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.054184e-02 | 1.296 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.637638e-02 | 1.249 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.966844e-02 | 1.224 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.921043e-02 | 1.228 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 6.034534e-02 | 1.219 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.338496e-02 | 1.273 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.728712e-02 | 1.242 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.915868e-02 | 1.228 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.774569e-02 | 1.238 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.581247e-02 | 1.253 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.178041e-02 | 1.209 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.308463e-02 | 1.200 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.315746e-02 | 1.200 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.564673e-02 | 1.183 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.593322e-02 | 1.181 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.593322e-02 | 1.181 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.593322e-02 | 1.181 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.613346e-02 | 1.180 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.639386e-02 | 1.178 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.659374e-02 | 1.177 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.669075e-02 | 1.176 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.669075e-02 | 1.176 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.708562e-02 | 1.173 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.975522e-02 | 1.156 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.010804e-02 | 1.154 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.045851e-02 | 1.152 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.097218e-02 | 1.149 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.116309e-02 | 1.148 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.116309e-02 | 1.148 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.293583e-02 | 1.137 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.475905e-02 | 1.126 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 7.606924e-02 | 1.119 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 7.606924e-02 | 1.119 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 7.606924e-02 | 1.119 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.627519e-02 | 1.118 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.627519e-02 | 1.118 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.627800e-02 | 1.118 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.653616e-02 | 1.116 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.895781e-02 | 1.103 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.148569e-02 | 1.089 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 8.260030e-02 | 1.083 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 8.260030e-02 | 1.083 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.260030e-02 | 1.083 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 8.260030e-02 | 1.083 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 8.260030e-02 | 1.083 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.291318e-02 | 1.081 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.463418e-02 | 1.072 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.554421e-02 | 1.068 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 8.554421e-02 | 1.068 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.674867e-02 | 1.062 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.737871e-02 | 1.059 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.737871e-02 | 1.059 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.737871e-02 | 1.059 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.069077e-01 | 0.971 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.069077e-01 | 0.971 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.069077e-01 | 0.971 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.069077e-01 | 0.971 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.175677e-01 | 0.930 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.175677e-01 | 0.930 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.238424e-02 | 1.034 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.006651e-01 | 0.997 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.079162e-01 | 0.967 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.079162e-01 | 0.967 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.154462e-01 | 0.938 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.989431e-02 | 1.046 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.527670e-02 | 1.021 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.589259e-02 | 1.018 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.175677e-01 | 0.930 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.117506e-01 | 0.952 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.578628e-02 | 1.019 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.175677e-01 | 0.930 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.907014e-02 | 1.050 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.023847e-01 | 0.990 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.238424e-02 | 1.034 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.735558e-02 | 1.012 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.175677e-01 | 0.930 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.011616e-01 | 0.995 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.528237e-02 | 1.021 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.005105e-01 | 0.998 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.008856e-01 | 0.996 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.959800e-02 | 1.048 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.117506e-01 | 0.952 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.376508e-02 | 1.028 | 1 | 1 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.568673e-02 | 1.019 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.128986e-01 | 0.947 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.069077e-01 | 0.971 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.921496e-02 | 1.003 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.068374e-02 | 1.042 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.117506e-01 | 0.952 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.124898e-02 | 1.040 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.196223e-01 | 0.922 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.198417e-01 | 0.921 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.207540e-01 | 0.918 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.225533e-01 | 0.912 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.225533e-01 | 0.912 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.249483e-01 | 0.903 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.249483e-01 | 0.903 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.294369e-01 | 0.888 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.307145e-01 | 0.884 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.328272e-01 | 0.877 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.328272e-01 | 0.877 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.328272e-01 | 0.877 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.335518e-01 | 0.874 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.342853e-01 | 0.872 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.350146e-01 | 0.870 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.350146e-01 | 0.870 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.350146e-01 | 0.870 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.350146e-01 | 0.870 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.353926e-01 | 0.868 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.353926e-01 | 0.868 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.387677e-01 | 0.858 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.396247e-01 | 0.855 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.396641e-01 | 0.855 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.396641e-01 | 0.855 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.405800e-01 | 0.852 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.463562e-01 | 0.835 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.463562e-01 | 0.835 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.476857e-01 | 0.831 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.500474e-01 | 0.824 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.506078e-01 | 0.822 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.525063e-01 | 0.817 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.531659e-01 | 0.815 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.531659e-01 | 0.815 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.531659e-01 | 0.815 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.532836e-01 | 0.815 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.532836e-01 | 0.815 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.532836e-01 | 0.815 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.532836e-01 | 0.815 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.535983e-01 | 0.814 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.577673e-01 | 0.802 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.598261e-01 | 0.796 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.610641e-01 | 0.793 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.112999e-01 | 0.675 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.112999e-01 | 0.675 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.112999e-01 | 0.675 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.112999e-01 | 0.675 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.112999e-01 | 0.675 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.112999e-01 | 0.675 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.112999e-01 | 0.675 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.880094e-01 | 0.726 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.880094e-01 | 0.726 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.880094e-01 | 0.726 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.880094e-01 | 0.726 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.880094e-01 | 0.726 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.166438e-01 | 0.664 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.166438e-01 | 0.664 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.166438e-01 | 0.664 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.166438e-01 | 0.664 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.722730e-01 | 0.764 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.456233e-01 | 0.610 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.456233e-01 | 0.610 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.918827e-01 | 0.717 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.918827e-01 | 0.717 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.918827e-01 | 0.717 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.120144e-01 | 0.674 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.835173e-01 | 0.736 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.156294e-01 | 0.666 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.722848e-01 | 0.764 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.129327e-01 | 0.672 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.270459e-01 | 0.644 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.015049e-01 | 0.696 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.125361e-01 | 0.673 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.455189e-01 | 0.610 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.455189e-01 | 0.610 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.352322e-01 | 0.629 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.270459e-01 | 0.644 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.250223e-01 | 0.648 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.250223e-01 | 0.648 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.250223e-01 | 0.648 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.918827e-01 | 0.717 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.456233e-01 | 0.610 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.891806e-01 | 0.723 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.166438e-01 | 0.664 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.325734e-01 | 0.633 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.322656e-01 | 0.634 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.791561e-01 | 0.747 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.791561e-01 | 0.747 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.125361e-01 | 0.673 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.985539e-01 | 0.702 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.456233e-01 | 0.610 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.456233e-01 | 0.610 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.325734e-01 | 0.633 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.198847e-01 | 0.658 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.453238e-01 | 0.610 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.120144e-01 | 0.674 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.255880e-01 | 0.647 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.956440e-01 | 0.709 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.956440e-01 | 0.709 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.755235e-01 | 0.756 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.755235e-01 | 0.756 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.755235e-01 | 0.756 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.755235e-01 | 0.756 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.991128e-01 | 0.701 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.456233e-01 | 0.610 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.120144e-01 | 0.674 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.880782e-01 | 0.726 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.112999e-01 | 0.675 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.112999e-01 | 0.675 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.112999e-01 | 0.675 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.156294e-01 | 0.666 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.722848e-01 | 0.764 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.850754e-01 | 0.733 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.327035e-01 | 0.633 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.125361e-01 | 0.673 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.851212e-01 | 0.733 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.165904e-01 | 0.664 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.880094e-01 | 0.726 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.070233e-01 | 0.684 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.112999e-01 | 0.675 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.755235e-01 | 0.756 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.166438e-01 | 0.664 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.850585e-01 | 0.733 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.410228e-01 | 0.618 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.456233e-01 | 0.610 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 1.835173e-01 | 0.736 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.991128e-01 | 0.701 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.456233e-01 | 0.610 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.948445e-01 | 0.710 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 2.129327e-01 | 0.672 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.680979e-01 | 0.774 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 2.461390e-01 | 0.609 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.468687e-01 | 0.608 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.491213e-01 | 0.604 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.534690e-01 | 0.596 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.546229e-01 | 0.594 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.713065e-01 | 0.567 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.713065e-01 | 0.567 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.713065e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.713065e-01 | 0.567 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.713065e-01 | 0.567 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.713065e-01 | 0.567 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.713065e-01 | 0.567 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.713065e-01 | 0.567 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.713065e-01 | 0.567 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.713065e-01 | 0.567 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.713065e-01 | 0.567 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.713065e-01 | 0.567 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.267509e-01 | 0.486 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.267509e-01 | 0.486 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.267509e-01 | 0.486 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.267509e-01 | 0.486 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.267509e-01 | 0.486 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.779797e-01 | 0.423 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.779797e-01 | 0.423 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.779797e-01 | 0.423 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.779797e-01 | 0.423 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.779797e-01 | 0.423 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.779797e-01 | 0.423 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 2.747300e-01 | 0.561 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.747300e-01 | 0.561 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.253133e-01 | 0.371 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.253133e-01 | 0.371 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.326048e-01 | 0.478 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 3.326048e-01 | 0.478 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.326048e-01 | 0.478 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.326048e-01 | 0.478 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.746147e-01 | 0.561 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.959289e-01 | 0.529 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.610790e-01 | 0.442 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.610790e-01 | 0.442 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.610790e-01 | 0.442 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.610790e-01 | 0.442 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.610790e-01 | 0.442 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.690476e-01 | 0.329 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 4.690476e-01 | 0.329 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.690476e-01 | 0.329 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.690476e-01 | 0.329 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.690476e-01 | 0.329 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 4.690476e-01 | 0.329 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.690476e-01 | 0.329 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.662668e-01 | 0.575 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.662668e-01 | 0.575 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.662668e-01 | 0.575 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.173352e-01 | 0.498 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.836175e-01 | 0.547 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.836175e-01 | 0.547 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.560365e-01 | 0.592 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.387623e-01 | 0.470 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.011287e-01 | 0.521 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.601440e-01 | 0.444 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.601440e-01 | 0.444 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.601440e-01 | 0.444 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.165338e-01 | 0.380 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.165338e-01 | 0.380 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.094560e-01 | 0.293 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.094560e-01 | 0.293 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.094560e-01 | 0.293 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.094560e-01 | 0.293 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.094560e-01 | 0.293 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.094560e-01 | 0.293 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.717238e-01 | 0.566 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.850732e-01 | 0.545 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.814198e-01 | 0.419 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.162631e-01 | 0.500 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.706461e-01 | 0.568 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.542027e-01 | 0.451 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.433437e-01 | 0.353 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.433437e-01 | 0.353 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.025341e-01 | 0.395 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.025341e-01 | 0.395 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.396503e-01 | 0.469 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.234363e-01 | 0.373 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.534914e-01 | 0.452 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.673730e-01 | 0.435 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.440811e-01 | 0.353 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.948175e-01 | 0.306 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.400325e-01 | 0.468 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.951852e-01 | 0.403 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.951852e-01 | 0.403 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.242812e-01 | 0.372 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.187573e-01 | 0.497 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.165338e-01 | 0.380 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.165338e-01 | 0.380 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.747300e-01 | 0.561 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.252215e-01 | 0.488 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.601440e-01 | 0.444 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.747300e-01 | 0.561 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.746147e-01 | 0.561 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.844397e-01 | 0.315 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.933038e-01 | 0.307 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.552588e-01 | 0.593 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.779797e-01 | 0.423 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.610790e-01 | 0.442 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.364619e-01 | 0.473 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.367663e-01 | 0.360 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.018313e-01 | 0.299 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.326048e-01 | 0.478 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.037769e-01 | 0.517 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.165338e-01 | 0.380 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.656220e-01 | 0.576 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.395865e-01 | 0.357 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.776187e-01 | 0.321 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.851931e-01 | 0.314 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.610790e-01 | 0.442 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.890866e-01 | 0.410 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.601440e-01 | 0.444 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.644276e-01 | 0.333 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.906530e-01 | 0.408 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.779797e-01 | 0.423 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.779797e-01 | 0.423 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.690476e-01 | 0.329 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.165338e-01 | 0.380 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.094560e-01 | 0.293 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.896432e-01 | 0.409 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.396503e-01 | 0.469 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.326048e-01 | 0.478 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.908525e-01 | 0.536 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.073496e-01 | 0.512 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.933038e-01 | 0.307 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.662668e-01 | 0.575 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.172254e-01 | 0.380 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.212120e-01 | 0.375 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.811532e-01 | 0.419 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.713065e-01 | 0.567 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 3.267509e-01 | 0.486 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.267509e-01 | 0.486 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.747300e-01 | 0.561 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.037769e-01 | 0.517 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.037769e-01 | 0.517 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.253133e-01 | 0.371 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.253133e-01 | 0.371 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.690476e-01 | 0.329 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 4.690476e-01 | 0.329 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.165338e-01 | 0.380 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.165338e-01 | 0.380 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.850732e-01 | 0.545 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.433437e-01 | 0.353 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.864889e-01 | 0.543 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.433437e-01 | 0.353 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.543201e-01 | 0.451 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.747300e-01 | 0.561 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.253133e-01 | 0.371 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.173352e-01 | 0.498 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.708557e-01 | 0.567 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.779917e-01 | 0.423 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.440811e-01 | 0.353 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.778000e-01 | 0.321 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.130749e-01 | 0.384 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.816065e-01 | 0.550 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.253133e-01 | 0.371 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.690476e-01 | 0.329 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.675796e-01 | 0.330 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.706750e-01 | 0.327 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.545882e-01 | 0.342 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.892986e-01 | 0.410 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.598278e-01 | 0.337 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.449981e-01 | 0.462 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.162631e-01 | 0.500 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.162631e-01 | 0.500 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.985604e-01 | 0.525 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.795977e-01 | 0.553 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.850732e-01 | 0.545 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.247992e-01 | 0.372 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.941148e-01 | 0.306 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.941148e-01 | 0.306 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.941148e-01 | 0.306 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 3.779797e-01 | 0.423 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.747300e-01 | 0.561 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.253133e-01 | 0.371 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.959289e-01 | 0.529 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.094560e-01 | 0.293 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.719418e-01 | 0.430 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.198010e-01 | 0.495 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.948175e-01 | 0.306 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.912888e-01 | 0.309 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.912888e-01 | 0.309 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.011287e-01 | 0.521 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.932688e-01 | 0.533 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.252215e-01 | 0.488 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.387623e-01 | 0.470 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.267509e-01 | 0.486 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.088992e-01 | 0.388 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.950720e-01 | 0.403 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.253133e-01 | 0.371 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.690476e-01 | 0.329 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.890866e-01 | 0.410 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.601440e-01 | 0.444 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.094560e-01 | 0.293 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.009973e-01 | 0.521 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 4.948175e-01 | 0.306 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.421920e-01 | 0.354 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.837740e-01 | 0.416 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.212120e-01 | 0.375 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.933038e-01 | 0.307 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.800046e-01 | 0.420 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.822949e-01 | 0.317 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.747300e-01 | 0.561 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.871261e-01 | 0.542 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.040855e-01 | 0.297 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.022158e-01 | 0.520 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.637986e-01 | 0.439 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 4.690476e-01 | 0.329 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.690476e-01 | 0.329 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.433437e-01 | 0.353 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.433437e-01 | 0.353 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.383242e-01 | 0.471 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.934620e-01 | 0.405 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.934620e-01 | 0.405 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.089733e-01 | 0.510 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.747300e-01 | 0.561 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.116825e-01 | 0.385 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.838207e-01 | 0.416 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.690476e-01 | 0.329 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.094560e-01 | 0.293 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.574605e-01 | 0.589 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.949967e-01 | 0.530 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.610790e-01 | 0.442 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.367663e-01 | 0.360 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.396503e-01 | 0.469 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.242812e-01 | 0.372 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.779259e-01 | 0.321 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.601440e-01 | 0.444 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.025341e-01 | 0.395 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.677710e-01 | 0.330 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 3.945044e-01 | 0.404 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.099067e-01 | 0.293 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.099067e-01 | 0.293 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.099067e-01 | 0.293 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.099067e-01 | 0.293 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.193952e-01 | 0.285 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.193952e-01 | 0.285 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.193952e-01 | 0.285 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.193952e-01 | 0.285 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.193952e-01 | 0.285 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.210168e-01 | 0.283 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.233372e-01 | 0.281 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.233372e-01 | 0.281 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.233372e-01 | 0.281 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.237830e-01 | 0.281 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.262581e-01 | 0.279 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.350294e-01 | 0.272 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.386105e-01 | 0.269 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.421710e-01 | 0.266 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.421710e-01 | 0.266 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.423405e-01 | 0.266 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.430250e-01 | 0.265 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.431602e-01 | 0.265 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.431602e-01 | 0.265 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.431602e-01 | 0.265 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.431602e-01 | 0.265 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.431602e-01 | 0.265 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.431602e-01 | 0.265 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.431602e-01 | 0.265 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.431602e-01 | 0.265 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.431602e-01 | 0.265 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.439633e-01 | 0.264 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.461739e-01 | 0.263 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.463576e-01 | 0.263 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.467914e-01 | 0.262 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.467914e-01 | 0.262 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.467914e-01 | 0.262 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.467914e-01 | 0.262 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.467914e-01 | 0.262 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.467914e-01 | 0.262 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.467914e-01 | 0.262 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.467914e-01 | 0.262 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.467914e-01 | 0.262 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.467914e-01 | 0.262 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.467914e-01 | 0.262 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.467914e-01 | 0.262 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.467914e-01 | 0.262 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.509214e-01 | 0.259 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.567570e-01 | 0.254 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.581378e-01 | 0.253 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.583868e-01 | 0.253 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.605666e-01 | 0.251 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.605666e-01 | 0.251 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.651042e-01 | 0.248 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.660938e-01 | 0.247 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.660938e-01 | 0.247 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.660938e-01 | 0.247 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.709275e-01 | 0.243 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 5.812872e-01 | 0.236 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 5.812872e-01 | 0.236 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.812872e-01 | 0.236 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.812872e-01 | 0.236 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.812872e-01 | 0.236 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.812872e-01 | 0.236 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.812872e-01 | 0.236 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.812872e-01 | 0.236 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.818281e-01 | 0.235 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.873925e-01 | 0.231 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.881851e-01 | 0.230 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.881851e-01 | 0.230 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.881851e-01 | 0.230 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.914519e-01 | 0.228 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.959791e-01 | 0.225 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.959791e-01 | 0.225 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.959791e-01 | 0.225 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.959791e-01 | 0.225 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.959791e-01 | 0.225 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.959791e-01 | 0.225 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.013274e-01 | 0.221 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.036885e-01 | 0.219 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.061576e-01 | 0.217 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.062399e-01 | 0.217 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.062399e-01 | 0.217 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.081120e-01 | 0.216 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.094293e-01 | 0.215 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.094293e-01 | 0.215 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.110501e-01 | 0.214 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.129714e-01 | 0.213 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.131593e-01 | 0.212 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.131593e-01 | 0.212 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.131593e-01 | 0.212 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.131593e-01 | 0.212 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.131593e-01 | 0.212 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.131593e-01 | 0.212 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.131593e-01 | 0.212 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.131593e-01 | 0.212 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.131593e-01 | 0.212 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.131593e-01 | 0.212 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.131593e-01 | 0.212 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.131593e-01 | 0.212 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.131593e-01 | 0.212 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.131593e-01 | 0.212 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.131593e-01 | 0.212 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.178373e-01 | 0.209 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.180269e-01 | 0.209 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.182227e-01 | 0.209 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.208062e-01 | 0.207 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.239289e-01 | 0.205 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.246395e-01 | 0.204 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.294760e-01 | 0.201 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.294760e-01 | 0.201 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.298273e-01 | 0.201 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.310876e-01 | 0.200 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.324183e-01 | 0.199 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.337008e-01 | 0.198 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.337008e-01 | 0.198 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.365487e-01 | 0.196 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.411459e-01 | 0.193 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.426070e-01 | 0.192 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.426070e-01 | 0.192 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.426070e-01 | 0.192 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.426070e-01 | 0.192 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.426070e-01 | 0.192 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.426070e-01 | 0.192 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.426070e-01 | 0.192 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 6.426070e-01 | 0.192 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.426070e-01 | 0.192 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.426070e-01 | 0.192 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.426070e-01 | 0.192 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.426070e-01 | 0.192 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.426070e-01 | 0.192 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.426070e-01 | 0.192 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.441377e-01 | 0.191 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.454874e-01 | 0.190 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.454874e-01 | 0.190 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.454874e-01 | 0.190 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.456826e-01 | 0.190 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.493849e-01 | 0.187 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.493849e-01 | 0.187 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.493849e-01 | 0.187 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.554448e-01 | 0.183 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.554448e-01 | 0.183 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.559575e-01 | 0.183 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.597704e-01 | 0.181 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.610022e-01 | 0.180 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.610022e-01 | 0.180 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.610022e-01 | 0.180 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.610022e-01 | 0.180 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.610022e-01 | 0.180 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.610022e-01 | 0.180 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.610022e-01 | 0.180 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.633183e-01 | 0.178 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.681119e-01 | 0.175 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.681119e-01 | 0.175 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 6.681119e-01 | 0.175 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.681119e-01 | 0.175 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.698148e-01 | 0.174 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 6.698148e-01 | 0.174 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.698148e-01 | 0.174 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.698148e-01 | 0.174 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.729184e-01 | 0.172 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.760189e-01 | 0.170 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.760189e-01 | 0.170 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.808156e-01 | 0.167 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.843433e-01 | 0.165 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.845295e-01 | 0.165 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.845981e-01 | 0.165 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.854072e-01 | 0.164 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.905383e-01 | 0.161 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.905383e-01 | 0.161 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.920567e-01 | 0.160 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.949527e-01 | 0.158 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 6.949527e-01 | 0.158 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.949527e-01 | 0.158 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.949527e-01 | 0.158 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 6.949527e-01 | 0.158 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.981460e-01 | 0.156 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.981460e-01 | 0.156 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.993273e-01 | 0.155 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.993273e-01 | 0.155 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.031289e-01 | 0.153 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.031289e-01 | 0.153 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.031289e-01 | 0.153 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.041315e-01 | 0.152 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.045625e-01 | 0.152 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.052488e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.061882e-01 | 0.151 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.151379e-01 | 0.146 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.158529e-01 | 0.145 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.180953e-01 | 0.144 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.180953e-01 | 0.144 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.180953e-01 | 0.144 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.180953e-01 | 0.144 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.181782e-01 | 0.144 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.181782e-01 | 0.144 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.181782e-01 | 0.144 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.181782e-01 | 0.144 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.181782e-01 | 0.144 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.181782e-01 | 0.144 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.181782e-01 | 0.144 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.194532e-01 | 0.143 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.194532e-01 | 0.143 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.194532e-01 | 0.143 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.194532e-01 | 0.143 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.311417e-01 | 0.136 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.311417e-01 | 0.136 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.350141e-01 | 0.134 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.350141e-01 | 0.134 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.378488e-01 | 0.132 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.396367e-01 | 0.131 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.396367e-01 | 0.131 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.396367e-01 | 0.131 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.396367e-01 | 0.131 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.396367e-01 | 0.131 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.396367e-01 | 0.131 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.437080e-01 | 0.129 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.437080e-01 | 0.129 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.437080e-01 | 0.129 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.437080e-01 | 0.129 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.437080e-01 | 0.129 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.437080e-01 | 0.129 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.437080e-01 | 0.129 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.462180e-01 | 0.127 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.477108e-01 | 0.126 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.478011e-01 | 0.126 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.478011e-01 | 0.126 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.498333e-01 | 0.125 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.498333e-01 | 0.125 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.523831e-01 | 0.124 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.558016e-01 | 0.122 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.572951e-01 | 0.121 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.594624e-01 | 0.119 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.594624e-01 | 0.119 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.594624e-01 | 0.119 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.594624e-01 | 0.119 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.594624e-01 | 0.119 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.594624e-01 | 0.119 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.594624e-01 | 0.119 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.609314e-01 | 0.119 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.637420e-01 | 0.117 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.639333e-01 | 0.117 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.639333e-01 | 0.117 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.639333e-01 | 0.117 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.639333e-01 | 0.117 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.639333e-01 | 0.117 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.653030e-01 | 0.116 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.653030e-01 | 0.116 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.674305e-01 | 0.115 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.674305e-01 | 0.115 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.674305e-01 | 0.115 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.773379e-01 | 0.109 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.773379e-01 | 0.109 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.773379e-01 | 0.109 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.773379e-01 | 0.109 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.777796e-01 | 0.109 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.777796e-01 | 0.109 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.777796e-01 | 0.109 | 1 | 1 |
| Protein methylation | R-HSA-8876725 | 7.777796e-01 | 0.109 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.786040e-01 | 0.109 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.830336e-01 | 0.106 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.875146e-01 | 0.104 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.893316e-01 | 0.103 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.893316e-01 | 0.103 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.893316e-01 | 0.103 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.893316e-01 | 0.103 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.893316e-01 | 0.103 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.900711e-01 | 0.102 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.900711e-01 | 0.102 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.900711e-01 | 0.102 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.942184e-01 | 0.100 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.942184e-01 | 0.100 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.947029e-01 | 0.100 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 7.947029e-01 | 0.100 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.947029e-01 | 0.100 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.947029e-01 | 0.100 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.947029e-01 | 0.100 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.947029e-01 | 0.100 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.947029e-01 | 0.100 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.947029e-01 | 0.100 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.947029e-01 | 0.100 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.947029e-01 | 0.100 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.947029e-01 | 0.100 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.947029e-01 | 0.100 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.947029e-01 | 0.100 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.996237e-01 | 0.097 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.996237e-01 | 0.097 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 7.996237e-01 | 0.097 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.996237e-01 | 0.097 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.996237e-01 | 0.097 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.021574e-01 | 0.096 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.021574e-01 | 0.096 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.021574e-01 | 0.096 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.031964e-01 | 0.095 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.098903e-01 | 0.092 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.098903e-01 | 0.092 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.098903e-01 | 0.092 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.103384e-01 | 0.091 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.103384e-01 | 0.091 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.103384e-01 | 0.091 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.103384e-01 | 0.091 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.103384e-01 | 0.091 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.103384e-01 | 0.091 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.118538e-01 | 0.091 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.136215e-01 | 0.090 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.136215e-01 | 0.090 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.136215e-01 | 0.090 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.159442e-01 | 0.088 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.161508e-01 | 0.088 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.189445e-01 | 0.087 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.201972e-01 | 0.086 | 1 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.244879e-01 | 0.084 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.244879e-01 | 0.084 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.244879e-01 | 0.084 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.244879e-01 | 0.084 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.245709e-01 | 0.084 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.247839e-01 | 0.084 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.247839e-01 | 0.084 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.247839e-01 | 0.084 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.247839e-01 | 0.084 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.247839e-01 | 0.084 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.247839e-01 | 0.084 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.247839e-01 | 0.084 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.247839e-01 | 0.084 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.247839e-01 | 0.084 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.247839e-01 | 0.084 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.279957e-01 | 0.082 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.279957e-01 | 0.082 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.279957e-01 | 0.082 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.282330e-01 | 0.082 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.296482e-01 | 0.081 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.347812e-01 | 0.078 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.347812e-01 | 0.078 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.347812e-01 | 0.078 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.347812e-01 | 0.078 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.347812e-01 | 0.078 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.347812e-01 | 0.078 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.347812e-01 | 0.078 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.347812e-01 | 0.078 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.347812e-01 | 0.078 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.355826e-01 | 0.078 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.355826e-01 | 0.078 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.361879e-01 | 0.078 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.366563e-01 | 0.077 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.366563e-01 | 0.077 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.366563e-01 | 0.077 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.381300e-01 | 0.077 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.381300e-01 | 0.077 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.381300e-01 | 0.077 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.434099e-01 | 0.074 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.445257e-01 | 0.073 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.445257e-01 | 0.073 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.445257e-01 | 0.073 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.449381e-01 | 0.073 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.449381e-01 | 0.073 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.504602e-01 | 0.070 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.504602e-01 | 0.070 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.504602e-01 | 0.070 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.504602e-01 | 0.070 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.504602e-01 | 0.070 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.504602e-01 | 0.070 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.504602e-01 | 0.070 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.504602e-01 | 0.070 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.504602e-01 | 0.070 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.504602e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.504602e-01 | 0.070 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.528529e-01 | 0.069 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.528529e-01 | 0.069 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.537452e-01 | 0.069 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.537452e-01 | 0.069 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.537452e-01 | 0.069 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.537452e-01 | 0.069 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.578871e-01 | 0.067 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.604128e-01 | 0.065 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.604128e-01 | 0.065 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.604128e-01 | 0.065 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.618519e-01 | 0.065 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.618519e-01 | 0.065 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.618519e-01 | 0.065 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.618519e-01 | 0.065 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.618519e-01 | 0.065 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.618519e-01 | 0.065 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.624630e-01 | 0.064 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.624630e-01 | 0.064 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.624630e-01 | 0.064 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.676296e-01 | 0.062 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.719036e-01 | 0.060 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.719036e-01 | 0.060 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.719036e-01 | 0.060 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.723765e-01 | 0.059 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.723765e-01 | 0.059 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.723765e-01 | 0.059 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.723765e-01 | 0.059 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.723765e-01 | 0.059 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.723765e-01 | 0.059 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.723765e-01 | 0.059 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.723765e-01 | 0.059 | 1 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.764697e-01 | 0.057 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.784849e-01 | 0.056 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.784849e-01 | 0.056 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.810815e-01 | 0.055 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.820998e-01 | 0.054 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.820998e-01 | 0.054 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.820998e-01 | 0.054 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.820998e-01 | 0.054 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.820998e-01 | 0.054 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.820998e-01 | 0.054 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.820998e-01 | 0.054 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.843896e-01 | 0.053 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.858330e-01 | 0.053 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.858330e-01 | 0.053 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.873401e-01 | 0.052 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.896379e-01 | 0.051 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.910828e-01 | 0.050 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.910828e-01 | 0.050 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.910828e-01 | 0.050 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.910828e-01 | 0.050 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.910828e-01 | 0.050 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.910828e-01 | 0.050 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.910828e-01 | 0.050 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.910828e-01 | 0.050 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.927674e-01 | 0.049 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.927674e-01 | 0.049 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.927674e-01 | 0.049 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.927674e-01 | 0.049 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.927674e-01 | 0.049 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.927674e-01 | 0.049 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.927674e-01 | 0.049 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.932629e-01 | 0.049 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.983972e-01 | 0.047 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.993084e-01 | 0.046 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.993084e-01 | 0.046 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.993084e-01 | 0.046 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.993819e-01 | 0.046 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.993819e-01 | 0.046 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.993819e-01 | 0.046 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.021497e-01 | 0.045 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.033127e-01 | 0.044 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.054759e-01 | 0.043 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.054759e-01 | 0.043 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.054759e-01 | 0.043 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.070492e-01 | 0.042 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.070492e-01 | 0.042 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.070492e-01 | 0.042 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.070492e-01 | 0.042 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.070492e-01 | 0.042 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.095253e-01 | 0.041 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.095253e-01 | 0.041 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.112886e-01 | 0.040 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.112886e-01 | 0.040 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.119874e-01 | 0.040 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.125163e-01 | 0.040 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.132061e-01 | 0.039 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.141325e-01 | 0.039 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.141325e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.141325e-01 | 0.039 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.141325e-01 | 0.039 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.141325e-01 | 0.039 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.141325e-01 | 0.039 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.141325e-01 | 0.039 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.141325e-01 | 0.039 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.144143e-01 | 0.039 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.167648e-01 | 0.038 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.167648e-01 | 0.038 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.168187e-01 | 0.038 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.190617e-01 | 0.037 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.190617e-01 | 0.037 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.206765e-01 | 0.036 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.206765e-01 | 0.036 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.206765e-01 | 0.036 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.206765e-01 | 0.036 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.206765e-01 | 0.036 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.206765e-01 | 0.036 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.206765e-01 | 0.036 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.219221e-01 | 0.035 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.219221e-01 | 0.035 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.219221e-01 | 0.035 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.234775e-01 | 0.035 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.234775e-01 | 0.035 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.267221e-01 | 0.033 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.267221e-01 | 0.033 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.267221e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.267221e-01 | 0.033 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.267221e-01 | 0.033 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.267221e-01 | 0.033 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.267221e-01 | 0.033 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.267771e-01 | 0.033 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.267771e-01 | 0.033 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.276716e-01 | 0.033 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.286124e-01 | 0.032 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.288199e-01 | 0.032 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.293776e-01 | 0.032 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.297594e-01 | 0.032 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.313461e-01 | 0.031 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.315792e-01 | 0.031 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.323073e-01 | 0.030 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.323073e-01 | 0.030 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.323073e-01 | 0.030 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.323073e-01 | 0.030 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.356443e-01 | 0.029 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.357907e-01 | 0.029 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.365524e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.374671e-01 | 0.028 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.374671e-01 | 0.028 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.374671e-01 | 0.028 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.374671e-01 | 0.028 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.388758e-01 | 0.027 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.390185e-01 | 0.027 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.390620e-01 | 0.027 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.422339e-01 | 0.026 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.422339e-01 | 0.026 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.435852e-01 | 0.025 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.449522e-01 | 0.025 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.449522e-01 | 0.025 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.466376e-01 | 0.024 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.466376e-01 | 0.024 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.466376e-01 | 0.024 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.470585e-01 | 0.024 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.488450e-01 | 0.023 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.504144e-01 | 0.022 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.504716e-01 | 0.022 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.535666e-01 | 0.021 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.544641e-01 | 0.020 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.544641e-01 | 0.020 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.565266e-01 | 0.019 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.569308e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.579361e-01 | 0.019 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.579361e-01 | 0.019 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.581590e-01 | 0.019 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.593054e-01 | 0.018 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.593880e-01 | 0.018 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.601031e-01 | 0.018 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.611435e-01 | 0.017 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.611435e-01 | 0.017 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.611435e-01 | 0.017 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.611435e-01 | 0.017 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.611435e-01 | 0.017 | 1 | 1 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.611435e-01 | 0.017 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.619135e-01 | 0.017 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.641065e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.641065e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.641065e-01 | 0.016 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.641065e-01 | 0.016 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.641065e-01 | 0.016 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.641196e-01 | 0.016 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.652699e-01 | 0.015 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.659927e-01 | 0.015 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.666562e-01 | 0.015 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.668438e-01 | 0.015 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.668438e-01 | 0.015 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.674218e-01 | 0.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.674218e-01 | 0.014 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.677219e-01 | 0.014 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.677219e-01 | 0.014 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.678300e-01 | 0.014 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.688092e-01 | 0.014 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.693724e-01 | 0.014 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.693724e-01 | 0.014 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.695480e-01 | 0.013 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.705967e-01 | 0.013 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.708279e-01 | 0.013 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.717084e-01 | 0.012 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.717084e-01 | 0.012 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.717084e-01 | 0.012 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.720743e-01 | 0.012 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.727202e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.727299e-01 | 0.012 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.738663e-01 | 0.012 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.738663e-01 | 0.012 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.738663e-01 | 0.012 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.738663e-01 | 0.012 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.744938e-01 | 0.011 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.755983e-01 | 0.011 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.758597e-01 | 0.011 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.758597e-01 | 0.011 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.758597e-01 | 0.011 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.758597e-01 | 0.011 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.758597e-01 | 0.011 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.772636e-01 | 0.010 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.776780e-01 | 0.010 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.777125e-01 | 0.010 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.794024e-01 | 0.009 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.794024e-01 | 0.009 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.802402e-01 | 0.009 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.805052e-01 | 0.009 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.805052e-01 | 0.009 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.805363e-01 | 0.009 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.806225e-01 | 0.008 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.809738e-01 | 0.008 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.809738e-01 | 0.008 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.809738e-01 | 0.008 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.812053e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.824254e-01 | 0.008 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.824254e-01 | 0.008 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.828076e-01 | 0.008 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.830117e-01 | 0.007 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.837664e-01 | 0.007 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.837664e-01 | 0.007 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.845474e-01 | 0.007 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.850051e-01 | 0.007 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.851802e-01 | 0.006 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.861494e-01 | 0.006 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.861821e-01 | 0.006 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.869273e-01 | 0.006 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.869726e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.871713e-01 | 0.006 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.871713e-01 | 0.006 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.871713e-01 | 0.006 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.872064e-01 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.879466e-01 | 0.005 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.881828e-01 | 0.005 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.882497e-01 | 0.005 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.883552e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.886767e-01 | 0.005 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.890848e-01 | 0.005 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.891655e-01 | 0.005 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.892797e-01 | 0.005 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.892949e-01 | 0.005 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.897955e-01 | 0.004 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.898662e-01 | 0.004 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.906875e-01 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.906875e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.908463e-01 | 0.004 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.909866e-01 | 0.004 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.913028e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.914590e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.914590e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.914590e-01 | 0.004 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.918307e-01 | 0.004 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.920316e-01 | 0.003 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.926892e-01 | 0.003 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.931662e-01 | 0.003 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.931845e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.932219e-01 | 0.003 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.937395e-01 | 0.003 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.938553e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.939693e-01 | 0.003 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.943798e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.943798e-01 | 0.002 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.945887e-01 | 0.002 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.949035e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.950670e-01 | 0.002 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.951172e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.954438e-01 | 0.002 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.954438e-01 | 0.002 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.956370e-01 | 0.002 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.960409e-01 | 0.002 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.961132e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.963555e-01 | 0.002 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.967960e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.970147e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.972205e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.973877e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.973877e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.975355e-01 | 0.001 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.979063e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.979420e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.979421e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.980502e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.980993e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.980993e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.980993e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.983093e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.983787e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.985027e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.986171e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.986171e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.989107e-01 | 0.000 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.990709e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.991131e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.991419e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.992289e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.993122e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.993393e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.994217e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.995413e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.995997e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.996128e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.996128e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997184e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.997492e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997514e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.997599e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.997783e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998332e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998388e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.998625e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.998828e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998828e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999192e-01 | 0.000 | 1 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999380e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999428e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999626e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999645e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999698e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999773e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999780e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999787e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999822e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999876e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999893e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999920e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999921e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999955e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999962e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999962e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999963e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999976e-01 | 0.000 | 1 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999979e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999980e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999989e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999995e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |